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CHAPTER 1
Bacterial Ribosome Structure and Function
1.1 Introduction of bacterial ribosome. In living cells, genetic information is stored in
the genome as deoxyribonucleic acid sequences (DNA). A significant part of this
genome encodes for proteins, which are the heart of the functional tasks in all
organisms. According to the central dogma of molecular biology by Crick (1) (Figure
1.1), genetic information in the DNA is transcribed into messenger RNAs (mRNAs),
which are in their turn translated into polypeptides of amino acids, resulting in different
types of proteins (1). The replication of genetic information presented in DNA is carried
out by DNA polymerase (2). Transcription of DNA into mRNA is catalyzed by RNA
polymerases, and mRNA is translated into protein by the ribosome (3).

Figure 1.1 Central dogma of molecular biology. The central dogma represents
the three main cellular processes in bacteria, replication, transcription and
translation. Figure was generated by CorelDRAW.
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Each amino acid is encoded by triplets of bases called codons. In bacteria, the
translation start site in mRNA begins with the initiator codon AUG, followed by an open
reading frame sequence that is translated into a specific protein until the ribosome
reaches a stop codon (UAA, UAG or UGA) (4). The adaptor between the mRNA and the
amino acids is the transfer RNA (tRNA). Each tRNA comprises approximately 75
nucleotides with a conserved 3 nucleotides (-CCA) at the 3’-end, onto which an amino
acid is linked through an ester bond (5). There are 64 codons available for ~ 50 different
types of tRNAs in cells. For each amino acid, there is an enzyme that recognizes tRNA
with an anticodon complementary to the mRNA codon. This family of enzymes, called
tRNA synthetases, which aminoacylates (attaches an amino acid) tRNA through a
reaction driven by ATP hydrolysis. Aminoacylated-tRNA (aa-tRNA) is an active
substrate for entry into the ribosome (6, 7).
1.2 Structure and function of bacterial ribosomes. Ribosomes are large
ribonucleoprotein (RNP) complexes of approximately 2.3 MDa molecular weight (8),
located in the cytoplasm of both prokaryotic and eukaryotic cells that catalyze the
messenger ribonucleic acid (mRNA) directed synthesis of proteins during translation (9).
In bacteria, these asymmetric complexes consist of two unequal subunits made up of
three types of RNA molecules and more than 50 proteins. The small ribosomal subunit
(30S) has 0.8 MDa molecular weight, consists of 1,600 nucleotides, and contains 16S
ribosomal RNA (rRNA) and approximately 20 proteins (S1-S21). It reads out the genetic
information by matching up the mRNA codon to the cognate tRNA anticodon in the
decoding center (DC). The large subunit (50S) is approximately 1.5 MDa and contains
23S rRNA (about 2900 nucleotides), 5S rRNA (120 nucleotides), and more than 30
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proteins. When complexed with the small subunit, the large subunit catalyses peptidebond formation between the tRNA-attached amino acid and the growing polypeptide
chain in the peptidyl transferase center (PTC). The ribosome has three tRNA binding
sites: the A (aminoacyl or acceptor) site, the P (peptidyl) site, and the E (exit) site
(Figure 1.2) (8-11).

Figure 1.2 Schematic representation of the bacterial ribosome. The ribosome
(70S) comprises a small ribosomal subunit (30S) and a large ribosomal subunit
(50S). The 30S subunit consists of one rRNA strand (16S) and 20 ribosomal
proteins (rproteins). The 50S subunit consists of two rRNAs (23S and 5S) and 30
rproteins (9, 11). Figure was generated by CorelDRAW.
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Translation starts with the formation of the initiation complex, which involves the
interaction of a conserved CCUCC sequence on 16S rRNA with the Shine-Dalgarno
sequence (GGAGG) centered at position -8 on mRNA (12,13). This process also
involves three initiation factors (IF1, IF2, IF3) that help to select the initiator tRNA
charged with N-formylmethionine (N-fMet), and promote the association of the two
subunits. The initiation process leaves the initiator tRNA in the P site of the ribosome
and an empty A site ready to accept a new aa-tRNA. Elongation continues with cycles
of polypeptide chain elongation that can be divided into four steps: a) delivery of a
cognate aa-tRNA in a ternary complex with elongation factor EF-Tu and GTP to the A
site of the ribosome, b) accommodation of the aa-tRNA into the ribosomal A site, c)
peptide-bond formation in PTC, and d) translocation of mRNA and tRNAs in the active
site of the ribosome, making the A site available for a new aa-tRNA. This process is
terminated when a stop codon present at the A site leads to the release of the
polypeptide chain and the dissociation of the ribosome-mRNA-nascent complex (8-10,
14) (Figure 1.3).
To accomplish translation, large conformational changes must take place in the
ribosomal structure. These changes have been, in part, characterized by singlemolecule spectroscopy (15-17) and cryo-electron microscopy (cryo-EM) studies (18, 19)
based on abundant information from crystallographic structural studies (20, 21).
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Figure 1.3 Three major steps of translation in bacteria. Initiation, in which the two
ribosomal subunits are assembled together with the help of initiator factors (IF1,
IF2 and IF3) leaving the initiator tRNA in the P site. Elongation, in which an
appropriate tRNA binds the A site of the ribosome in a codon depend manner
elongates the peptide chain by an amino acid increment and termination, in
which there is dissociation of the ribosomal subunits and release of the protein
(15). Figure was generated by CorelDRAW.
1.2.1 Initiation of protein synthesis. When the anti-Shine-Dalgarno (anti-SD)
sequence at the 3’-end of 16S rRNA recognizes the universal Shine-Dalgarno (SD)
sequence of the mRNA, an initiator tRNA charged with formylated methionine (N-fMettRNAfMet) binds the 30S ribosomal subunit in its P site in a step reaction catalyzed by
three initiator factors: IF1, IF2 (GTPase protein) and IF3 (22, 23). The direct binding of
the initiator tRNA to the P site rather than the A site is explained by the interaction of
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A1339 and G1338 of 16S RNA with the G-C base pair 30-40 and 29-41 in the anticodon
stem via type I and II A-minor interactions. These base pairs, located between the P site
and E site, act as a gate to avoid the movement of the initiator tRNA to the E site until
the head of the 30S subunit rotates during ratcheting. Since the elongator tRNA lacks
the G-C base pairs at position 30-40 but have A-U base pairs instead, they have to pass
through the A site of the ribosome first (8, 10).
The efficiency of the initiation step depends on the initiation sequences, ShineDalgarno (SD) sequence, and the distance between SD and the initiator codon.
Experiments examining the order and timing of the binding of the initiator factors to the
30S suggest that IF2 and IF3 bind first to the 30S; subsequent association of IF1 is
required for the formation of a stable pre-initiation 30S complex. After the binding of
these factors, fMet-tRNAfMet binds this complex and interacts with mRNA followed by
conformational rearrangement, which leads to anticodon-codon recognition. This step is
followed by the 50S subunit association with the 30S subunit and dissociation of the
initiation factors after hydrolysis of GTP by IF2. A stable 70S initiator complex is then
formed with mRNA located around the neck of the 30S in a conformation that enables
the codon-anticodon to interact with each other. An empty A site is ready to accept an
appropriate aa-tRNA to its matched codon in the DC of the A site (24).
1.2.2 Peptide elongation and translocation. In the elongation phase, aa-tRNA in
complex with the elongation factor Tu (EF-Tu, GTPase protein) and GTP enter as a
ternary complex to the empty A site of the ribosome in response to cognate codonanticodon interaction. The initial binding state of this ternary complex is referred to as
the A/T state. When the codon-anticodon interaction is recognized by the ribosome,
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GTP is rapidly hydrolyzed to GDP in the GTPase association center (GAC). A cryo-EM
study from the Frank laboratory (25) addressed the question of how codon-anticodon
interactions in the DC of the 30S is communicated to the GAC located in the 50S
approximately 70 Å away. In their study, they discovered that the sarcin-ricin loop plays
a pivotal role in this process, and its deletion leads to loss of the GTPase activity. They
also found that tRNA in the A/T state has a different conformation than that of fully
accommodated tRNA in which a significant bend occurs between the D stem and the
anticodon arm that helps the elbow region of tRNA be in contact with the GTPase
center. From their data, the authors suggested that tRNA has an important role in
transmitting the signal from the DC to the GAC center. After the GTP hydrolysis, EF-Tu
loses its affinity for the ribosome, dissociates, and allows the acceptor stem of the tRNA
to be fully accommodated into the PTC in the 50S. The ribosome now has a peptidyl
tRNA in the P site and aminoacylated tRNA in the A site. The PTC center catalyzes a
peptide bond formation between these two tRNAs, elongating the peptide chain by one
amino acid, and the deacylated tRNA in the P site now moves to the E site to exit from
the ribosome. The latter step is called translocation that is catalyzed by another
elongation factor (EF-G, GTPase protein), which binds the A site, and induces
translocation. This process is repeated until a stop codon appears in the A site (8, 2628).
The ribosome uses two proofreading steps to accurately select the proper tRNA.
In general, only the cognate tRNAs are selected for GTP hydrolysis with high
probability; however, near cognate tRNAs are rejected. The first proofreading step
depends on the standard free energy difference between cognate and near-cognate
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tRNAs. During this step, base pairing between codon-anticodon forms a short double
helix (minihelix) in the decoding center. Crystal structures, chemical protection and
genetic studies suggest that the ribosome recognizes the geometry of the codonanticodon base pairing by inducing the flipping out of the bases A1492 and A1493 of the
internal loop of helix 44 of the 16S RNA, which causes the universally conserved base
G530 of the 530 loop to switch from its syn to anti conformation (Figure 1.4). These
changes in the decoding center region stabilize the interaction between the codonanticodon helix and the decoding center where A1493 and A1492 form hydrogen
bonding with the first and the second base pair of the codon-anticodon helix; however,
G530 makes contact with the second position of the anticodon and the third position of
the codon.

Figure 1.4 Decoding center conformational changes during codon-anticodon
interaction. a. The codon of mRNA in the A site (purple color) and the tRNA
anticodon stem-loop (gold). A1492 and A1493 of the 16S RNA (grey) and G530
that bind and stabilize the tRNA–mRNA complex are shown in red. Ribosomal
protein (orange). b. Recognition of the first base pair in which A1493 is making a
type I A–minor interaction with A36 from the tRNA and U1 from the mRNA.
Recognition of the second base pairs in which A1492 makes a type II A–minor
interaction with A35 and U2 is stabilized by G530. In the third base pair, no
limiting interactions are seen with G34 and U3 (8).
In this view, the first two base pairs of the codon-anticodon minihelix are monitored by
the ribosome that can discriminate between base pairing and mismatches. After GTP
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hydrolysis by EF-Tu, the selected tRNA passes through the second proofreading step.
During this step, an induced-fit mechanism is likely to occur that favors the increased
accommodation rates of cognate aa-tRNA versus near-cognate aa-tRNA. This step
involves the rotation of the body of tRNA pivoting around the anticodon-stem-loop
(ASL). This rotation is facilitated by the closure of the 30S subunit that occurs only when
there is a correct match between codon and anticodon bases. In contrast, near-cognate
tRNA fails to pass through this step (8, 29).
1.2.3 Termination of translation and ribosome recycling. When a stop codon (UUA,
UAG or UGA) enters the A site of the ribosome, a release factor (RF) binds to the A site
and induces hydrolysis of the ester bond between the nascent polypeptide chain and
the P site tRNA. Unlike the elongation step in which there is a nucleophilic attack by the
aminogroup of tRNA in the A site and the carboxylic group of tRNA in the P site, during
the termination step, a nucleophilic attack of a water molecule with the C-terminus of the
nascent polypeptide chain results in hydrolysis of the peptidyl chain from the P site. This
hydrolysis is subsequently followed by folding the protein into its functional form. There
are two types of release factors. Release factor I, RF1, recognizes the stop codons UAA
and UAG. Release factor II, RFII, recognizes the stop codon UGA. In the presence of
the ribosome recycling factor (RRF) and EF-G, the ribosome is recycled to a new round
of protein synthesis with a new mRNA (30, 31).
Structural studies of release factor I, RF1, revealed that RF1 is a structural mimic
of aa-tRNA. This factor is formed from four domains: domain 1, or the N-terminal
domain, is required during release of the ribosome by RF3; domain 2 has a PA(V)T/SPF
motif that is required for specific codon recognition; domain 3, the catalytic domain, has
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a glycine-glycine-glutamine (GGQ) motif that interacts with the PTC of the 50S and
leads to peptidyl-tRNA hydrolysis; and domain 4 plays a vital structural role. Crystal
structural studies of RF1 and RF2 reveal similarities in their structure (Figure 1.5) (32,
33).

Figure 1.5 Structural study of RF1 from Thermotoga maritima shows the three
domains. Domain 1(yellow) the catalytic domain. Domain 3 or GGQ domain (red)
for ester bond hydrolysis. Domain 2/4 or PVT domain (blue) for codon recognition
(33).
1.3 Ribosome dynamics. The progression of tRNA through the ribosome is one of the
most complicated steps during translation. Late in the 1960s, Bretscher and Spirin
predicted independently that the translocation of tRNA through the ribosome is coupled
to intersubunit movements; therefore, tRNAs must have intermediate states in addition
to their classical states (34, 35). This hypothesis was tested by chemical footprinting
experiments later in 1989 by Noller’s laboratory (36). Noller and coworkers showed that
translocation occurs in two steps. In the first step, the acceptor stem of tRNA moves
relative to the 50S subunit, forming hybrid-state intermediates in which the acceptor part
of tRNAs moved with respect to the 50S subunit, but the anticodon part remained in
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their original states relative to the 30S subunit. The first letter of the abbreviations A/P
and P/E refers to the first letter of the binding site on the small ribosomal subunit, and
the second letter refers to the binding site on the large ribosomal subunit. The second
step is catalyzed by the elongation factor G (EF-G) that translocates the bottom part of
tRNA to the adjacent ribosomal site forming a post-translocational state P/P and E/E
(36, 37). Later, a cryo-EM study from the Agrawal laboratory revealed the ribosome’s
ratchet-like mechanism, in which the small ribosomal subunit rotates counterclockwise
relative to the large subunit. In this view, tRNA appeared in its hybrid state conformation
(38). The Noller laboratory also revealed a spontaneous movement of tRNA between
the classical and hybrid state in solution. Therefore, the ribosomal ratchet-like model
and tRNA hybrid conformations converged during translocation (39). These results were
confirmed by single-molecule FRET studies (40-42).
1.3.1 Ribosome ratcheting mechanism. The dynamic nature of the ribosome and its
relation to translation was explained extensively by ribosome ratcheting. This
mechanism was first described by a three-dimensional cryo-EM study by Frank and
Agrawal in the mid 2000s (38). By stalling different functional states of the ribosome into
complexes containing elongation factor G in the presence of non-hydrolysable GTP
(either EF-G.GDPNP or EFG.GDP.fusidic acid), the data showed that prior to
translocation, the small ribosomal subunit rotates counterclockwise at an angle of about
6 ± 0.7 degrees relative to the large ribosomal subunit. This rotation results in a
displacement of the periphery of the ribosome by 19 ± 7 Å. After translocation, the small
ribosomal subunit rotates back by 3 ± 0.7 degrees. Interestingly, these conformational
changes were observed with and without mRNA and tRNA, leading to the suggestion
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that this ratcheting-like conformation is a property of the ribosome itself. This model was
tested directly by an elegant study from the Noller laboratory. In this study, the
intersubunit movements of the ribosome were trapped by forming a disulfide bridge
between ribosomal proteins S6 in 30S and L2 in 50S (43). Later in 2008, Noller in
collaboration with Taekjip Ha successfully monitored the ratchet-like motion in real time
by fluorescently labeling the ribosomal subunits (44). They found a spontaneous
rotation of the ribosomal subunits between rotated and non-rotated states in a
pretranslocation complex. This rotation is coupled to the identity of tRNA in the P-site.
Deacylated tRNA favors a rotated state; however, acylated tRNA favors a non-rotated
state of the ribosome. On the other hand, in the post-translocation state, the fluctuation
between the intersubunits disappeared (44).
1.3.2 tRNA fluctuation inside ribosomes. Cryo-electron microscopy maps of
ribosomes in complex with mRNA and tRNA during accommodation of cognate aatRNA suggest that aa-tRNA adopts a bent or twist conformation in the A/T state.
Accommodation of a cognate aa-tRNA involves relaxation of the tRNA structure by an
approximate 45° rotation around the anticodon stem-loop (ASL). Prior to translocation,
deacylated tRNA bound to the P site fluctuates spontaneously between classical (P/P)
and hybrid (P/E) states in the pre-translocation (PRE) complex. During translocation,
A/A and P/P tRNAs, respectively, pass through the hybrid intermediate A/P and P/E
states to reach the P/P and E/E states. Formation of A/P and P/E intermediates is
promoted by the rotation of the A and P site tRNA bodies, respectively. The formation of
the first intermediate A/P is assisted by the movement of the elbow region of tRNA by
less than 3 Å from its classical position A/A. With the second intermediate P/E, the
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tRNA body moves the E site by ~ 15-20 Å. Recently, a single-molecule study suggested
that this transition depends on the identity of tRNA (16, 45, 46).
1.3.3 L1 stalk motion during ribosomal ratcheting. The L1 stalk is a structural
feature of the ribosome formed from the helices H76, H77 and H78 of the 23S RNA in
large ribosomal subunits and the L1 protein. The structure of this stalk mimics a halfmushroom in which H76 represents the stem and H77, H78 and L1 protein mimic the
cap of the mushroom. The role of the L1 stalk during translocation has been studied
extensively by cryo-EM, single-molecule spectroscopy, and other biochemical tools (19,
47). It has been shown that deletion of this stalk lowers the rate of protein synthesis and
destabilizes the hybrid P/E state. Previous studies have shown at least three different
positions of the L1 stalk during translocation. In the open conformation, the L1 stalk
points away from the ribosomal body especially from the inter-subunit region between
the small and large ribosomal subunits and when the E site is vacant from tRNA. In the
half-closed conformation, the deacylated tRNA occupies the E/E state of the posttranslocation complex. The transition from the open to half-closed conformation, the L1
stalk moves toward the intersubunit region by 30 to 40 Å. In the closed conformation,
the deacylated tRNA occupies the P/E site. This step requires an additional movement
of the L1 stalk by 15 to 20 Å toward the intersubunit region, interacting with the elbow
region of tRNA in the E site (15, 48-50)
1.4 Ribosome rescue system.
1.4.1 Causes and effects of stalled ribosomes. Proper termination cannot occur on
mRNA that is rich with a cluster of rare codons or damaged mRNAs resulting from
nuclease cleavage, translational frameshifting or incompletely transcribed mRNA
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lacking a stop codon (51), the ribosome stalls at the end of such mRNAs. Stalled
ribosomes result in two major problems: first, partially synthesized protein may not
function or fold correctly and could form toxic aggregates in the cell. Second, depletion
of the ribosomal pool that is available for translation (52); however, these two problems
can be resolved in bacteria by a rescue process called trans-translation, which employs
a noncoding RNA (tmRNA) and its cofactor (SmpB).
Although ssrA and smpB genes, encoded as tmRNA and SmpB, respectively,
are completely conserved in eubacteria, it has been found in several species such as
Escherichia coli and Bacillus subtilis, stalled ribosomes can be rescued even in ΔssrA
bacterial strains, in which the ssrA gene is knocked out. The cells are still viable and
grow well, indicating an alternative mechanism of the trans-translation. This mechanism
involves a small 140 amino acid basic protein called YaeJ. It contains two domains. The
N-terminal domain mimics domain 3 of the release factors 1 and 2 (RF1 and RF2) with
the conserved catalytic motif GGQ; however, unlike RF1 and RF2, YaeJ is missing the
domains 2 and 4 that are responsible for stop codon recognition. The C-terminal domain
of YaeJ is rich with basic amino acids, unstructured in solution and essential for esterbond hydrolysis. A mutation in this region could lead to the loss of protein activity.
Previous studies have shown that YaeJ is able to hydrolyze the peptidyl-tRNA ester
bond in the P site of a stalled ribosome on non-stop and no-go mRNAs in vivo. A recent
crystal structure of YaeJ protein in a stalled ribosome shows that the N-terminal globular
domain of YaeJ binds the A site of the 50S near the PTC center and the C-terminal
domain binds the mRNA pathway in the 30S. Interestingly, the C-terminal tail of YaeJ
that is unstructured in solution forms a α helix rich in positively charged amino acids and
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binds the A site of the stalled ribosome in the same manner as the SmpB protein in the
tmRNA-SmpB system. Although YaeJ mimics mRNA in its binding to the DC region, it is
not suited in the presence of a codon in the A site (53-55).
Another alternative pathway of the ribosome rescue process was discovered by
Tatsuhiko and coworkers (56). This mechanism is active to compensate for the loss of
the tmRNA-SmpB activity and is based on a peptide-encoded by yhdl gene. In his
study, Tatsuhiko and coworkers found that this peptide leads to release of stalled
ribosome in S30 translation reaction, and based on its activity, they renamed yhdl
alternative ribosome recue factor A (arfA) (56). Tatsuhiko and coworkers have reported
that ~ 83% of arfA transcripts include a hairpin structure at their 3’ coding region that
can be degraded by ribonuclease III, leading to a non-stop codon mRNA. Therefore,
translation of these transcripts can be controlled by the tmRNA-SmpB system.
However, when the tmRNA-SmpB system is incapacitated, ArfA is released from the
ribosome and accumulates inside the cell.
In this dissertation, the focus is on trans-translation to understand the entrance
and accommodation of this complex inside the stalled ribosome in addition to structural
characterization of the tmRNA-SmpB complex and dynamics of tRNA inside ribosomes.
Trans-translation occurs approximately 13,000 times per cell division, one out of
every 250 regular translational events. In addition to its role as protein quality control,
this mechanism is required for viability, virulence, development, and response to stress
in many bacterial systems (57).
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1.4.2 Discovery, structure and function of transfer-messenger RNA (tmRNA).
Transfer-messenger RNA, also called small stable RNA A (SsrA) or 10Sa RNA,
consists of 363 nucleotides in Escherichia coli. It was discovered in 1978 by Apirions
and coworkers as a small stable RNA with an unknown function (58). Transfermessenger RNA was first named 10Sa RNA because of its sedimentation speed of
10S. Transfer-messenger RNA was found to be encoded by the ssrA gene, and its
disruption caused a reduction in the rate of cell growth (58). Transfer-messenger RNA
represents approximately 10% of ribosomal RNA in Escherichia coli, corresponding to
one tmRNA for every 10-20 ribosomes. It gets transcribed as a precursor of 457
nucleotides from a single gene, and its transcription is controlled by σ70 promoter and a
rho-independent transcriptional terminator (59). The pre-tmRNA can be cleaved by
cellular endo/exonucleases that remove the 5’ and 3’ unnecessary nucleotides to create
a mature acceptor arm that can be charged with alanine. Seven nucleotides were
removed by RNase P creating a 5’ mature end; however, the maturation of the 3’-end
involves multiple RNases; like all canonical tRNAs, tmRNA has a trinucleotide CCA at
its 3-terminus. This trinucleotide is not encoded by the ssrA gene, but it is posttranscriptionally added by tRNA nucleotidyl transferase. Transfer-messenger RNA has
properties of both tRNA and mRNA. The 5’ and 3’ ends of tmRNA form the tRNA-like
domain (TLD) and fold into a structure that resembles alanyl-tRNA. The TLD can be
subdivided into four domains resembling the cloverleaf features of tRNA including the
acceptor stem, the TψC arm, and the D loop, and, instead of the anticodon stem found
in tRNA, the TLD domain has an irregular helix H2 that is formed from several stems
interrupted by loops (18, 59, 60). H2 links the TLD to the mRNA-like domain (MLD)
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through pseudoknot 1. The MLD contains an internal ORF, encodes a ten amino acid
tag (ANDENYALAA), which is connected by a single-stranded region to several RNA
helices with, in most cases, four pseudoknots (PK1-PK4), and single-stranded RNAs in
between (Figure 1.6) (18, 52, 57).

Figure 1.6 Secondary structure of tmRNA. The upper part of tmRNA shows the
TLD that resembles an alanyl-tRNA and links by pk1 to the MLD. The latter
encodes 10 amino acids before reaching its stop codon UAA. The pk2, pk3 and
pk4 link the 3’ end of MLD to the other part of the TLD (60) .
Transfer-messenger RNA is a three-fold system used to rescue the stalled
ribosomes by charging the nascent polypeptide chain with alanine. This alaninecharged RNA enters the ribosome to act first as alanine-tRNA and then uses its open
reading frame to add a tag at the C-terminus of the nascent polypeptide and offers a
stop codon, which enables a normal termination to take place.
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1.4.3 SmpB is a cofactor of tmRNA. The SmpB protein is an essential component of
the rescue system. This protein is involved in a variety of events in trans-translation. It
can bind tmRNA with high affinity, forming a 1:1 complex with a KD in a low nanomolar
range (59, 61). SmpB can protect tmRNA from degradation inside the cells; the half-life
of tmRNA in the absence of SmpB is three-fold shorter than in its presence. It can also
enhance the alanylation of the TLD of tmRNA. Moreover, SmpB is required for the
stable association and accommodation of tmRNA inside the ribosome. Previous studies
have shown that SmpB acts as a recruiter for tmRNA to interact with the ribosome;
however, other studies have suggested that the binding of SmpB alone to the ribosome
is possible only in the presence of high salt conditions (62-64). The NMR structure of
this protein reveals a positively charged molecule with an isoelectric point 9.9. It has two
oligonucleotide-binding (OB) fold regions that resemble other RNA-binding proteins,
such as IF1. These OB folds are formed from a closed barrel core made from six
antiparallel β strands surrounded by three α helices. These two conserved regions of
OB (Figure 1.7) were suggested to be a tmRNA and a ribosome binding sites. In
addition to the β barrel structure, the 160 amino acid protein has an unstructured Cterminal tail in solution, but it has been shown that this part of SmpB folds into a helical
structural when interacting with the ribosome (65).
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.
Figure 1 7 NMR structure of SmpB protein.The structure reveals a β barrel in the
center surrounded by three α helices and an unstructured C-terminal tail
connected by each other through loops. The green and blue highlighted regions
correspond to the two conserved regions found on the surface of this protein.
Figure was generated by PyMOL.
The tmRNA-SmpB system is conserved throughout the bacterial kingdom. It has
been proposed that tmRNA and SmpB are part of ribonucleoprotein complex that
contains, in addition to tmRNA and SmpB, RNase R, ribosomal protein S1,
phosphoribosyl pyrophosphate synthetase and a protein with an unclear function
encoded by the yfbG gene (66).
1.4.4 Trans-translation mechanism. Although tmRNA was discovered in 1978, the
trans-translation mechanism was not described until 1995. The most likely reasons for
this delay are the high efficiency of releasing the stalled ribosomes as well as the short
half-life of tmRNA tagged proteins, which is less than 2 minutes in E.coli. Therefore,
observation of tagged proteins or ribosomes interacting with tmRNA was very unlikely
(57, 62).
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The first evidence for trans-translation came from studies of murine interleukin-6
(IL-6) that was overproduced in E. coli (67). Truncated IL-6 extracted from inclusion
bodies were terminated at various positions, and all had the peptide AANDENYALAA
attached to the C terminus. The 11 tag residues of the attached peptide except the first
alanine were found to be encoded by the ssrA gene although not in a canonical open
reading frame (68). Further studies found that this mechanism is efficient when the
defective mRNA has no more than six nucleotides after the P site codon. However, the
tagging process cannot be detected for mRNA with fifteen or more nucleotides after the
P site codon. Unlike in vitro studies, in vivo trans-translation occurs on both non-stop
mRNAs, where the ribosome stalls because the mRNA lacks or reads through a stop
codon, and on no-go mRNAs, where the ribosome stalls due to a lack of tRNA either
because the mRNA is rich in rare codons or tRNA is depleted. In this case, mRNA can
be cleaved from the 3’ end by ribonucleases or by a toxin such as RelE, which binds the
A site of the ribosome and cleaves the mRNA (57, 69).
The question of how the tmRNA-SmpB complex enters the stalled ribosome and
rescues it is still a mystery; however, based on extensive data from cryo-EM, a recent
crystallographic structure of the TLD-SmpB complex inside ribosome and biochemical
studies (70-72), the following mechanism (Figure 1.8) has been proposed. First, SmpB
binds tmRNA, which may enhance the alanylation of the 3’-end of tmRNA. After
aminoacylation by alanyltRNA synthetase (AlaRS), EF-Tu in the GTP binding state
binds to alanyl-tmRNA/SmpB, activating this quaternary complex to recognize the A site
of the stalled ribosome. The TLD acts as tRNA, while the other part of tmRNA forms an
arc around the 30S. Unlike the initiation of the translation in canonical tRNA, tmRNA
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initiates trans-translation without the initiation factors or the presence of the initiator
codon for fMet-tRNA. Instead, a sequence upstream of the open reading frame in
tmRNA seems to be involved in placing the first codon of the MLD in the A site of the
stalled ribosome with the help of the SmpB protein.

Figure 1.8 Trans-translation mechanism. Transfer-messenger RNA acts first as
a tRNA, entering the ribosomal A site and becoming a substrate for
transpeptidation. In this reaction, the alanine charged the 3’ end of tmRNA is
added to the C-terminus of the nascent protein. The reading frame then switches
from the mRNA to the open reading frame of tmRNA, resulting an addition of a
tmRNA-encoded peptide tag to the C-terminus substrate protein. This peptide tag
contains multiple proteolytic determinants, which targets the substrate protein for
rapid degradation by a number of intracellular proteases (52). Figure was
generated by CorelDRAW.
When entering the ribosomal A site, the TLD-SmpB complex becomes a substrate for
transpeptidation. During this step, the nascent polypeptide transfers to alanyl-tmRNA
and the reading frame then switches from the defective mRNA to the open reading
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frame of tmRNA, resulting in the addition of 10 amino acid tag (ANDENYALAA) to the
C-terminus of nascent polypeptide. When the stop codon in the MLD reaches the A site,
it facilitates the normal termination and recycling of the ribosomal subunits (57, 62, 73).
The degradation of the incompletely synthesized protein is initiated when the C-terminal
tag is recognized by ClpX triggering the ClpXP proteases. Other proteases such as
ClpAP and Lon, membrane associated protease such as FtsH or periplasmic protease
like Tsp (Tail-specific-protease) and proteases adaptors such as SspB and ClpS can
also contribute to degradation (57, 62, 73).
Trans-translation may facilitate RNA degradation when releasing the ribosome
from the 3’-end and exposing the mRNA to RNases such as RNase R. Removal of the
defective RNA is essential to avoid repeated cycles of the translation initiation followed
by trans-translation. During trans-translation, the ribosome can be recycled without the
recycling factor (RRF), suggesting that tmRNA may have intrinsic ribosome recycling
activity (74).
1.5 Dissertation summary. The main goal of this research is to dissect the mechanistic
details of the trans-translation. To reach this goal, we first characterized the structure of
the tmRNA-SmpB complex in solution. Then, we developed an assay to monitor the
tRNA dynamics inside the ribosome. Lastly, we investigated how the tmRNA-SmpB
complex identifies and binds stalled ribosomes using single-molecule spectroscopy.
This technique uniquely suited this study of the molecular dynamics involved in this
process because it allowed us to more fully understand the trans-translation
mechanism. To accomplish these goals, we developed the following three aims:
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1.5.1 Aim 1. Determination of the SmpB-tRNA-like domain conformation in
solution and the effect of metal ions. Transfer-messenger RNA (tmRNA) and SmpB
are the main components of the trans-translation rescue machinery that releases stalled
ribosomes from defective mRNAs. Little is known about how SmpB binding affects the
conformation of the tRNA-like domain (TLD) of tmRNA. It has been previously
hypothesized that the absence of a D stem in the TLD provides flexibility in the elbow
region of tmRNA, which can be stabilized by its interaction with SmpB. Here, we used
Förster resonance energy transfer (FRET) to characterize the global structure of the
TLD in the presence and absence of SmpB and as a function of magnesium
concentration. For this purpose, we attached a donor fluorophore, fluorescein (F), and
an acceptor fluorophore, tetramethylrhodamine (TAMRA or R), to the 5’ and 3’ ends of
the TLD of tmRNA (tmRNAΔ). For comparison and as a negative control for SmpB
binding, we also used regular tRNA (tRNAΔ) and mitochondrial tRNA (mtRNAΔ).
Surprisingly, our data showed that the global conformation and flexibility of tmRNA does
not change upon SmpB binding; however, magnesium ions induce an 11 Å compaction
in the tmRNA structure, suggesting that the flexibility in the H2a stem may allow
different conformations of tmRNA as the tRNA like domain (TLD) and mRNA like
domain (MLD) need to be positioned differently while moving through the ribosome.
1.5.2 Aim 2. Develop a single-molecule assay to monitor tmRNA accommodation
into a stalled ribosome. Protein elongation is a dynamic process during which tRNA
traverses the ribosomal binding sites along a path of approximately 100 Å that requires
large structural rearrangements of the tRNA and ribosome. Prior to translocation,
deacylated tRNA bound to the P site fluctuates spontaneously between classical (P/P)
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and hybrid (P/E) states in the pretranslocation (PRE translocation) complex. During
translocation, A/A and P/P tRNAs pass through the hybrid intermediate A/P and P/E
states within a solvent-accessible channel formed by the interface of large and small
ribosomal subunits. Upon release of EF-G, the ribosome returns to the nonrotated or
classical conformation and the tRNAs move to the P/P and E/E sites. Here, we
developed an assay to monitor the tRNA dynamics inside the ribosome by using singlemolecule protein induced fluorescence enhancement (sm-PIFE) to study the dynamics
of tRNA inside the ribosome. Our results reveal changes in the Cy3-labeled tRNA
fluorescence intensity caused by changes in the environment of the fluorophore. We
show that these changes are sensitive to the magnesium concentration and the
presence of antibiotics. We also observe two populations of tRNA in the ribosome: a
static one, in which the ribosome may be in the unlocked state, and a dynamic one, in
which the tRNA switches between different sub-states at a constant rate. These two
populations are consistent with spontaneous ribosomal ratcheting.
1.5.3 Aim 3. Study of tmRNA entrance and accommodation in the ribosome at the
single-molecule level. During trans-translation, it has been hypothesized that the TLD
of tmRNA enters the A site of a stalled ribosome, thereby replacing the defective mRNA
and targeting the incomplete protein for proteolysis. Based on previous studies on
cognate tRNA accommodation, we hypothesized that the accommodation of tmRNA
inside a stalled ribosome is a multistep process. To test this hypothesis, we used smFRET by developing a labeling approach in which a FRET donor on the P site PhetRNAPhe and a FRET acceptor on the SmpB protein. Measuring the FRET efficiency
between the two fluorophores monitors accommodation of tmRNA into the stalled
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ribosome. Our data reveal tmRNA accommodation dynamics in real time.
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CHAPTER 2
Methods
To characterize biomolecular interactions and structural dynamics in healthy and
stalled protein synthesis machinery, several methods have been employed. While
single-molecule fluorescence resonance energy transfer (sm-FRET) has emerged as a
powerful tool for mechanistic investigations of increasingly complex biochemical
systems, this technique in addition to bulk fluorescence spectroscopy and other
biochemical assays will be applied to address the aims of this thesis. In this chapter, a
detail description of the general methods that are applied will be described.
2.1 Fluorescence Spectroscopy. By absorbing light at specific wavelength within its
absorption or excitation spectrum, a fluorophore, mostly an organic compound, has the
ability to excite, and re-emit the fluorescence at longer wavelength within its emission
spectrum. Each fluorophore has a unique absorbance and emission spectrum that is
mirror to each other that gives each fluorophore an identity. This identity depends on
many properties, such as, maximum excitation and emission wavelengths, quantum
yield, extinction coefficient and lifetime in the exciting state (75). The progression of the
fluorophore upon light absorption can be described by the Jablonski diagram (Figure
2.1). According to this diagram, when absorbing light, the electrons of the fluorophore in
the ground state (S0) get excited and move to the vibrational levels of the excited state.
In the excitation state, the electrons rotate or vibrate down to get a semi-stable state
level (S1) (internal conversion). The electrons emit photons when they go from the
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excited state back to the ground state. If the emitted energy is within the emission
spectrum, there is radiative relaxation (KF). If the electrons from the excited level (S1) do
intersystem crossing, the electrons enter to the triplet state (T1) that has slightly lower
energy than the S1 state. At that level the electrons can go to the ground state by
emitting photon, but this process is too slow (10-3-10s), and called phosphorescence, or
it can go to the ground state without emitting the light, non-radiative energy. The
electrons can go back and forth between the T1 and S1 state, when it emits back from
the S1 state, this process called delayed fluorescence.

Figure 2.1 Jablonski diagram. By absorbing light, the fluorophore gets excited
and promotes its electrons from the ground state (S0) to the excited state (S1). In
the excited state the electrons move down to the lower level of the excited state
(thermal relaxation) before emitting photons. By internal conversion, the
electrons can move to the dark state (T1) from which they can go back to the
ground state by a slow process called phosphorescence (75). Figure was
generated by CorelDRAW
Excited fluorophores are highly sensitive to the environment and the dynamic
process of the molecules of interest. Fluorescence properties can present large
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variations with the molecular environment making fluorophores attractive probes to
characterize biomolecular interactions (75).
2.2 Fluorescence resonance energy transfer. Fluorescence resonance energy
transfer (FRET) or Förster resonance energy transfer, was first described by Theodor
Förster in 1940 as a long range non-radiative energy transfer process that occurs
between a donor and an acceptor fluorophores within a distance of 5-100 Å from each
other (76, 77). Since the interaction between the two fluorophores is based on dipoledipole coupling, the rate constant for energy transfer is inversely proportional to the
sixth power of the distance between them. Fluorescence resonance energy transfer
also depends on the mutual orientation of the two fluorophores, the refractive index of
the medium, the quantum yield of the donor in the absence of the acceptor and the
overlap between the emission spectrum of the donor and the excitation spectrum of the
acceptor (Figure 2.2).
Fluorescence resonance energy transfer is distance-dependent between the
electrons in the excited states of the donor and the acceptor closed by. This distance is
inversely proportional to the FRET as shown in the following equation:

(2.1)

Where R0 is the Förster distance at which 50% of the energy is transferred from the
donor to the acceptor.
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Figure 2.2 FRET efficiency characteristics.Upper panel. The FRET efficiency is
proportional on the donor molecules that have transferred excitation state energy
to the acceptor molecules, increases with decreasing the intermolecular distance
between the donor and the acceptor. R0, is defined when 50% of FRET efficiency
is transferred to the acceptor. Lower panel. Spectrum overlap between the
excitation of the donor and the emission of the acceptor, here is shown the Cy3
donor and the Cy5 acceptor.
To determine R, the distance between donor and acceptor fluorophore, it is required to
know the R0 that is dependent on the quantum yield of the donor, φD, dipole orientation

30

factor, κ2, refractive index of the medium, n, is estimated to be near that of water (n=
1.33), and J (λ), overlap between the donor emission and the acceptor absorption. R0
was calculated according to the following equation;
(2.2)

Figure 2.3 Common pairs of fluorophores used for FRET measurement. Cy3 and
Cy5 is a common donor-acceptor pair for single-molecule and fluorescein and
tetramethylrhodamine is a common donor-acceptor pair in the bulk fluorescence
spectroscopy experiments such as steady-state and tr-FRET.

To apply FRET to any biological system, the endogenous fluorophores are
covalently attached to the biomolecules of interest. Selecting the position of the
fluorophore is critical since the fluorophore should not alter the structure or biological
activity of the biomolecule under study. Attaching a fluorophore to a biomolecule, the

31

latter must have a specific reactive group such as primary amines or thiol moieties. For
FRET experiments, the distance between the donor and acceptor fluorophores should
be close enough to their Förster distance, where the FRET efficiency presents the
maximum sensitivity with distance variation. Fluorescence resonance energy transfer
has the advantage to detect a change in the structure of a molecule, it has been used
exclusively as a molecular ruler to measure the distance between the two fluorophores
intra or intermolecular (78).
For simplicity, FRET efficiencies were calculated as an apparent FRET.
Fluorescence intensities of the donor (ID) and the acceptor (IA) were measured and the
following equation was applied:

(2.3)

2.3 Fluorescence anisotropy. Fluorescence anisotropy has been widely used in
biochemical studies, such as, RNA-protein and protein-protein interactions, protein
denaturation, environment viscosity, and many others. Anisotropy measurements are
based on the principle of selecting of excited photons of fluorophores by polarized light.
In isotropic media like water, fluorophores are randomly oriented. Under irradiation with
polarized light, only molecules with transition moments oriented parallel to the electric
vector of the incident photons are excited. Emission also occurs with the light polarized
along a fixed axis in the fluorophore. During the fluorescence emission time window, the
fluorophore orientation may change. Consequently, polarization of the emitted light will
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vary concomitantly with the fluorophores reorientation (Figure 2.4).

Figure 2.4 Schematic drawing for the measurement of fluorescence. The
polarizer light that photoselects the photons and only the molecules that have
transition moments oriented parallel to the electric vector of the incident photons
are excited. Emission also occurs with the light polarized along a fixed axis in the
fluorophore. During the fluorescence emission time window, the fluorophore
orientation may change. Consequently, polarization of the emitted light changes
with the fluorophores reorientation Figure was generated by CorelDRAW.
Fluorescence anisotropy (r) is defined by:

(2.4)

In which, I|| and I⊥ are the fluorescence intensities of the vertically and horizontally
polarized emission respectively, when the sample is excited with vertically polarized
light. G, is an empirically determined, instrument dependent correction factor.
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As small molecules rotate in the picoseconds time scale (compared to
nanoseconds fluorescence lifetime), fluorophores in non-viscous media typically present
anisotropies close to zero; however, when they bound to bigger biomolecules such as
proteins, the above-mentioned rotational motions become slower and take place in the
nanoseconds time scale. These movements compete then with the fluorescence
emission and result an increase in anisotropy. The Perrin equation relates fluorescence
anisotropy with the rotational correlation time:

(2.5)

In which, r0 is the fundamental anisotropy, θ is the rotational correlation time of a
fluorophore and τ, is the fluorescence lifetime. For globular proteins, θ can be estimated
with the following equation:

(2.6)

In which, R, is the gas constant, η is the viscosity, T the temperature, V is the
specific volume of the protein. (75, 79-81).It is clear from the above equation that the
bigger proteins will present higher θ values. For example, a 20 kDa protein has a θ of
~10 ns, a value already larger than the lifetime of the fluorescein (~ 4 ns in water).
2.4 Steady-state FRET. For steady-state FRET, a donor fluorophore is excited with a
continuous light and the donor and acceptor emissions spectra were monitored. To
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accomplish this experiment, a commercially available spectrophotometer (Carry
Eclipse fluorescence spectrophotometer) is used. This spectrophotometer uses a
Xenon lamp that generates a continuous light source. This light can excite the donor
fluorophore of the sample in a quartz cuvette (Quartz Fluorometer Micro Cell, Starna
Cells, Inc.). The emission spectra of the donor and acceptor are recorded. For
example, Fluorescein is excited at 490 nm (10 nm bandwidth) and fluorescein and
tetramethylrhodamine (TAMRA) emissions are measured at 520 nm and 580 nm (5
nm bandwidth), respectively. Likewise, Cy3 is excited at 555 nm (10 nm bandwidth)
and Cy3 and Cy5 emissions are measured at 565 nm and 665 nm (5 nm bandwidth),
respectively (82-84). The emission intensities of both donor and acceptor fluorophores
are used to calculate the apparent FRET efficiency as shown in the equation (2.3)
2.5

Time-correlated

single-photon

counting

(TCSPC).

The

time-resolved

fluorescence measurements were performed using TCSPC. The experiment is initiated
with a pulse of light split into 2 paths: one is directed to the fluorophore sample and the
other is directed to a detector that triggers the TAC (time-to-amplitude converter). This
device generates a voltage that increases linearly with time. When the first fluorescence
photon reaches the stop detector, a signal is sent to the TAC and the current voltage is
read by the analog-to-digital converter and transferred to a computer. By repeating this
process many times, a histogram with the number of photons detected per time window
is obtained. As the probability of detecting a photon at a certain time is proportional to
the fluorescence intensity at that time, the recorded histogram represents the form of
the fluorescence decay. The vast majority of modern TCSPC modules (including the
one used in this work) operate in “reverse mode” (Figure 2.5) (75, 85, 86).
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Figure 2.5 Schematic for TCSPC set-up. TCSPC used in this work indicating its
components: M (mirror), NDF (neutral density filter), S (sample), PMT
(photomultiplier), CFD (constant fraction discriminator), TAC (time-to-amplitude
converter) and ADC (analog-to-digital converter). Yellow line represents raw
laser light. Blue line represents polarized, intensity-attenuated and bandpassfiltered laser light. Fluorescence is shown as a purple line. Black lines connecting
TCSPC components stand for electric signals.
In this set-up, the fluorescence signal is used to start the TAC and the excitation signal
is used to stop it. Photon counting was limited to 1 photon per ~ 100 pulses in order to
prevent pile-up effect or biasing towards shorter decay times
2.6 Single-molecule. One of the greatest challenges for biochemists was the imaging
of a single molecule. When looking at the single-molecule level, information can be
obtained allow the exploration of masked molecular heterogeneities, and short-lived
intermediates in complex materials as well as permit uncovers key structural, dynamic
and functional information otherwise hidden in the ensemble-averaged bulk experiment.
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Single-molecule FRET fills the gap between the distance sensitivities of other
techniques such as NMR spectroscopy (< 1nm) and electron microscopy (> 10 nm),
makes it such an attractive tool to detect intermediates involved in aa-tRNA selection
during ribosomal translation (87, 88). Our lab uses TIR (Total Internal Reflection)-based
single-molecule spectroscopy with FRET detection. This technique was utilized to study
the accommodation of tmRNA in the ribosome. Total internal reflection has been
commonly used to reduce background signals by limiting the detection volume to a thin
sheet at the interface between a microscope slide and a solution. In this technique, a
prism-based TIRF set up was used with an inverted microscope (IX-71, Olympus,
Center Valley, PA) as shown in Figure 2.6. The molecules are immobilized on a quartz
slide (Finkenbeiner, Waltham, MA) that directly contacts the prism. A quartz PellinBroca prism (CVI Melles-Griot, Albuquerque, NM) is used with immersion oil (Cargille,
cedar Grove, NJ) in between prism and quartz slide surface. A laser beam (532 nm, 3
mW, Crystal Laser GCL-532-L, Reno, NV) reaches the quartz slide through a prism at
an incidence angle slightly larger than the critical angle leading to total reflection of the
beam that produces an evanescent wave that can excite the immobilized molecules
about 100-150 nm into the solution. The donor and acceptor intensities collected by the
objective are separated in a light tight box by using dichroic mirrors and passed to the
CCD (charge-coupled device) camera (Ixon+, DV-897E, Andor, South Windsor, CT)
(89).

37

Figure 2.6 Schematic diagram of prism-based TIRF. The excitation beam
reaches the interface of the slide-solution at an angle θ than is slightly larger than
the critical angle and creates an evanescent wave that excites immobilized
molecules on the slide. The emission from donor and acceptor are collected
through an inverted microscope objective and passed through a slit into a lighttight box, where the donor (green) and acceptor (red) emissions are physically
separated by dichroic mirror. These two emission signals are detected side-byside by an electron multiplied back illuminated CCD camera. The focal length of
the lens L1 is represented by f1, d and h are distances and height of mirror from
objective. The refractive indices for air, prism, and quartz slide and aqueous
solutions are nair, nq and nsol respectively. L1-L3, lenses, M1-M6, mirrors, DM1,
and DM2 are the dichroic mirrors. This figure is adapted from (92).
2.6.1 Slide preparation for single-molecule experiments. Quartz slides and
coverslips were prepared for single-molecule experiments as previously described (90).
In summary, two holes were drilled on the quartz slides as shown in the (Figure 2.7).
Since the slides can be recycled 12 times, it is important to clean them carefully to
remove any residues of impurities and the leftover sample from previous experiment.
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After incubating the slides with a mixture of alconox (VWR International Inc.) and water
overnight, the slides were boiled for 30 minutes to loosen the epoxy, coverslips and
double sticky tape. Any of these items that remain attached to the slide are removed
with a razor blade. Then, the slides are scrubbed for 2 minutes with a mixture of alconox
detergent powder and water. This step is followed by rinsing the slides with water, 100%
ethanol and water alternatively. Cleaned slides then boiled with an acid piranha solution
(3:1 ration of sulfuric acid: hydrogen peroxide) for 45 minutes. This step is followed by
carefully rinsing the slides with water using plastic tweezers. After rinsing, the slides
were dried with a Bunsen burner. The slides and coverslips were then functionalized
with an amino group by aminosilanization reaction (for 140 ml reaction: 100 ml of
methanol, 5 ml of acetic acid and 1 ml of VECTABONDTM reagent (3aminopropyltriethoxysilane Vector Laboratories, Inc., Burlingame, CA). This reaction
was followed by PEGylation via a mixture of methoxy polyethylene glycol succinimidyl
carboxymethyl (m-PEG-SCM, MW 5000, Laysan Bio, Inc., Arab, Al) and 10% biotin
polyethylene glycol succimidyl carboxymethyl (BIO-PEG-SCM, MW 3400/5000, Laysan
Bio, Inc.) in 0.1 M sodium bicarbonate at pH 8.5. After at least 4 hours incubation in a
humid chamber in the dark, the slides and coverslips were rinsed with distilled water,
dried and stored under Nitrogen (90).
2.6.2 Channel assembly. The cleaned slides were assembled as a sandwich like
channel that is formed by two layers of double sticky tape in between the slide and
coverslip. The periphery of the channel is sealed with epoxy as shown in (Figure 2.7).
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Figure 2.7 Single-molecule slide assembly (a) Top view of an assembled
microscope slide. (b) Microfludic channel preparation using two layers of doublesided tape between the quartz slide and cover slip. The assembly is sealed with
epoxy at the edges to prevent leaking from the channel. (c) Slide in b with an
attached flow tubing for injection of sample (90).
2.7 Single-molecule protein-induced fluorescence intensity. Protein-induced
fluorescence intensity (PIFE) is a complementary technique to sm-FRET that is
sensitive to a single nucleotide distance resolution. This photophysical phenomenon is
based on the status of the Cyanine 3 dye that has 2 rings in its structure linked by the
C-C double bond. Trans-state is the photoactive state; however, cis-state is the dark
state. When a protein approaches this fluorophore, the fluorophore becomes much
brighter. This brightness may enhance the quantum yield of the fluorophore (91, 92). To
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observe PIFE in our system, our lab uses TIR based single-molecule spectroscopy as
described in the previous section. Data were recorded at 33 milliseconds time
resolution.
2.8 Oxygen scavenging system. The presence of oxygen molecules in the solution
can cause the fluorophore during the laser excitation to go to the ‘dark’ state that can
interrupt the FRET and give false result. To avoid this problem, an oxygen scavenger
system can be introduced on the microscope slide. Oxygen-scavenging system (OSS)
is formed from 10% wt/vol glucose, 50 µg/ml glucose oxidase (Sigma, C2133 ≥ 100
kU/g) and 10 µg/ml catalase (Sigma, C3155 ≥ 35 kU/mg) (Figure 2.8A). The
preparation of OSS is done by dissolving ~ 25 µL of Glucose Oxidase and 6.2 µL of
Catalase in 50 µL of T50 Buffer (10 mM Tris-HCl pH 7.0, 50 mM NaCl). This solution
should be stored at 4°C and cannot be used for more than 3 days.
In addition to this system, an alternative system has been developed by the Puglisi’s
group to avoid a possible interference of the glucose oxidase enzyme to particular
biological system. This system involves protocatechuic acid/protocatechuate-3,4dioxygenase (PCA/PCD). The preparation of (PCA/PCD) is done by mixing 2 µL of PCD
with 8 µL of PCA in 190 µL of single-molecule imaging buffer. Moreover, the Ha’s group
has found that Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid,
ACROS Organics, Belgium), a vitamin E analogue, can help preventing blinking and
photobleaching of the fluorophore. A saturated Trolox solution (~ 2 mM) in water is a
better candidate to quench triplet state-related of the fluorophore (Figure 2.8B) (93, 94).
A stock saturated solution of Trolox was prepared by dissolving 5 mg of solid Trolox in
10 mL distilled water. The solution was shaken at room temperature for 30 minutes and
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filtered through a 0.2 µm syringe filter. This Trolox solution was used in the preparation
of buffers and OSS solution used in single-molecule experiments instead of distilled
water. In addition to Trolox, β-mercaptoethanol (BME) (Figure 2.8C) can also be used
as an antiblinking and antibleaching reagent.

Figure 2.8 Oxygen scavenging system for single-molecule study.(A) Schematic
of the chemical reaction showing how glucose oxidase converts dissolved O2 in
to H2O2 in the presence of glucose and decomposition of H2O2 back to the
molecular O2 in the presence of catalase. (B and C) Chemical structures of
Trolox (B) and β-Mercaptoethanol (C) commonly used as antiblinking and
antibleaching agents in single-molecule studies.
2.9 RNA-metal interaction. In addition to its role in the genetic information transporter,
RNA plays an important role inside the cells such as in the regulation of translation,
splicing and catalysis. A precisely folded RNA acts as a structural scaffold for its
function (95). Metals ions are required to maintain the folded RNA conformations. Since
RNA is folded in a hierarchical manner, the initial step in the folding pathway is the
formation of the secondary structure that can be stimulated by any positively charges
that can shield the repulsive charges originated from the close proximity of negatively
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charged backbones of RNA. In general, potassium or sodium ions are the most popular
monovalent ions that are used for secondary structure formation; however, to form a
tertiary structure that involves interactions of various secondary structure elements in
space, it often involves specific interactions with metal ions, mostly divalent ions such
as Mg2+. The stability of RNA by Mg2+ arises from two distinct binding modes, site
binding and diffuse binding. Diffused binding of Mg2+ to RNA is often termed outer
sphere interactions. These types of interaction involve water molecules in the
hydratation sphere. Magnesium ions form such a binding can be replaced by other
divalent or trivalent ions such as Ca2+, Mn2+ or cobalt (III). The other type of binding is
more specific and involve in the catalytic activity. This kind of interaction is direct or
inner sphere interaction. The ligands involved in forming these kind of interactions are
commonly phosphoryl oxygens, base keto groups (O6 of guanosins and O4 of uracil),
purine N7 heteroatoms and the 2’-OH of the ribose. For this purpose, hard metals such
as Mg2+ are able to form inner sphere interaction with hard ligands such as Oxygen.
This interaction is specific (95-97).
2.10 Preparation of 70S ribosomes and mRNAs. The 70S ribosome throughout this
thesis was prepared from Escherichia coli MRE600 strain or Escherichia coli K12 strain,
in which ssrA and smpB genes were knocked out, as previously described (98, 99).
From overnight culture, the cells were grown in Luria Broth (LB) media to mid-log phase
(OD600nm = 0.6) and slowly cooled to 15°C (to produce run-off ribosomes). The pellets
were collected after centrifugation and resuspended in buffer A (50 mM Tris-HCl pH 7.6,
100 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA), then passed through a chilled French
Press using a 3/8” diameter piston and 18,000 psi pressure. After 15 minutes of
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centrifugation, the concentration of ammonium chloride was adjusted to 0.5 M, followed
by ultracentrifugation for 4 hours, using Ti1270 rotor at 42,000 rpm speed. The pellets
were resuspended in buffer B (50 mM Tris-HCl pH 7.6, 0.5 M NH4Cl, 10 mM MgCl2, and
0.5 mM EDTA). The crude 70S obtained was purified by sucrose density gradient
followed by ultracentrifugation for 17 hours at 42,000 rpm. The pellets were dissolved in
ribosome storage buffer (10 mM Tris-HCl pH 7.5, 60 mM NH4Cl, 10 mM MgCl2),
aliquoted and flushed frozen in liquid Nitrogen and stored it at -80ºC. The ribosome
concentration was measured by UV-Vis from the absorbance at 260 nm after
background subtraction (ε260nm = 40,453,067 M-1 cm-1). The extinction coefficient was
taken from (http://openwetware.org/wiki/Sauer:P1vir_phage_transduction), Prof. Robert
T. Sauer (Department of Biology, Massachusetts Institute of Technology).
Messengers RNAs were designed from T7P10 gene, locus: Tag T7P10; location: (64757554). The constructs (Figure 2.9) were purchased from Keck Foundation
Biotechnology Resource Laboratory at Yale University School of Medicine (New Haven,
CT) as RNA with 2’-protection groups. The deprotection reaction was carried out
according to the manufacturer’s protocol (Glen’s Research). Briefly, RNAs were
dissolved in 200 µL of anhydrous dimethyl sulfoxide (DMSO) and heated to 65°C for 2-3
hours. Then, 125 µL of triethyamine trihydrofluoride were added, followed by desalting
with 3 M sodium acetate pH 5.3 and butanol precipitation (82). The pellets were washed
with 100% ethanol and dried under speed vacuum. The RNA was dissolved in water
and purified by denaturing gel electrophoresis (15% polyacrylamide dependent on the
length of the mRNA, 8M urea).
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Short strand 1: 5'- GGG AGU AAU UUU GUU GU GGC AAG GAG GUA AA UUU
AC-3’
Short strand 2: 5'- GGG AGU AAU UUU GUU GU GGC AAG GAG GUA AA
AUG UU-3’
PolyU: 5'- GGG AGU AAU UUU GUU GU GGC AAG GAG GUA AA UUU UUU
UUU UUU UUU-3’
mRNA1: 5'- GGG AGU AAU UUU GUU GU GGC AAG GAG GUA AA AUG UUU
UUU UUU UUU-3’
DNA splint # 1: 5’- AAC AAA ATT ACT CCC –3’ biotin
Figure 2.9 Messengers RNA sequences used in the study. Short strand 1
represents the stalled mRNA sequence that has five nucleotides in its open
reading frame UUU in the P site. Strand 2 represents the stalled mRNA
sequence with AUG codon in the P site. Long strand represents the stalled
mRNA sequence with fifteen polyU nucleotides in its open reading. The first
fifteen nucleotides in all three stalled mRNAs, represents the part of the
sequence that is going to hybridize to the biotinylated DNA (DNA splint # 1), the
shine-Dalgarno sequence is underlined and the open reading frame are bolded.
The RNA band was crushed and soaked in the elution buffer (0.4 M ammonium acetate,
0.1% SDS, and 0.1 mM EDTA) at 4°C overnight using soft rotation. After
phenol/chloroform extraction and ethanol precipitation, the purification continued with
C8 reverse-phase HPLC with a linear acetonitrile gradient with 0.1 M triethylammonium
acetate (TEAA pH 7.4). RNA concentration was measured by UV-Vis from the
absorbance at 260 nm after background subtraction.
2.11 Fluorophore labeling. The pellets of pure RNAs were dissolved in 11 µl water. A
14 µl of the dye was added (200 mg of the flurophore was dissolved in 14 µl of dimethyl
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sulfoxide (DMSO)), the volume was completed to 100 µl by the labeling buffer (100 mM
sodium tetraborate buffer pH 8.5). The reaction was vortexed and tumbled on a tube
shaker overnight (16 to 20 hours) at room temperature. After the labeling reaction was
completed, the excess fluorophore was removed and the labeled and unlabeled nucleic
acids were separated via HPLC. Briefly, the reaction was ethanol precipitated with 100
nmol GTP, and resuspended in 100 µL HPLC Buffer (0.1 M TEAA, pH 7.4 and 5%
acetonitrile). The labeled and unlabeled fractions were separated by HPLC and the
labeled fractions were dried under vacuum and resuspended in distilled water. The RNA
concentration was measured by UV-Vis after background subtraction and stored at
-20°C (78).
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CHAPTER 3
Fluorescence Characterization of the tRNA-like Domain of tmRNA in Complex
with SmpB (61)
Adapted from Daher M. and Rueda D. Fluorescence Characterization of the tRNA-like
Domain of tmRNA in Complex with SmpB. Biochemistry, 2012, 51(17): 3531-8.
3.1 Introduction to tmRNA-SmpB complex structure and function. The Escherichia
coli tmRNA is quite stable in vivo, presenting a half-life of approximately two minutes
(57). This stability is highly dependent on the interaction between tmRNA and its
cofactor protein SmpB. It has been shown that in the absence of SmpB, the degradation
rate of tmRNA increases dramatically (64, 100). In addition to increasing the stability of
tmRNA, this protein is also involved in trans-translation. Therefore, studying the
structure of the tmRNA-SmpB complex will provide a better understanding of the transtranslation.
A transient electric birefringence (TEB) study of the TLD in absence of SmpB has
revealed a more obtuse angle (110° instead of 90°) between the acceptor and helix H2a
stems compared to canonical tRNAs (101). Two crystal structures of the TLD-SmpB
complex have been solved (102, 103). The first crystal structure by Ban and coworkers
(Figure 3.1A) showed that SmpB binds the single-stranded D and the connector loop of
TLD, but could not resolve the structure of the acceptor stem and the upper part of the
D loop (102). This missing part was modeled as an extended helix based on a transient
electric birefringence study. The second crystal structure by Yokoyama and coworkers
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(Figure 3.1B) revealed the complete structure of the TLD-SmpB complex, and
confirmed the presence of an obtuse angle between the acceptor stem and the helix
H2a, but a 90˚angle between the acceptor stem and SmpB (103). Based on this result,
the authors suggested that SmpB mimics a canonical acceptor stem and interacts with
the decoding site, while the H2a arm functions as a class II tRNA long variable arm.

Figure 3.1 Crystal structure of TLD of tmRNA in complex with SmpB. A. TLDSmpB structure from Ban’s laboratory (1P6V) shows the binding of SmpB to the
elbow region of TLD and reveals the obtuse angle between the H2a stem and the
modeled acceptor stem. B. TLD-SmpB structure from Yokoyama’s laboratory
(2CZJ) confirms the SmpB binding site in the elbow region of TLD and the
extended structural conformation between the acceptor stem and the H2a stem.
The latter crystal structural suggests that SmpB mimics the anticodon stem of the
canonical tRNA as shown in this figure. Figure was generated by PyMOL.
Little is known about how SmpB binding affects the conformation of TLD of
tmRNA. It has been previously hypothesized that the lack of the D stem in the TLD may
provide flexibility in the elbow region of tmRNA between H2 and the acceptor arm,
which can be stabilized by its interaction with SmpB (102). In particular, it is not yet
known whether SmpB and/or Mg2+ ions modulate the TLD structure. To address this
question, we used fluorescence anisotropy and FRET to measure the distance between
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the acceptor and the H2a stem in the presence and absence of SmpB. We also
compared our results to a canonical tRNA that has the full D stem and a mitochondrial
tRNA (mtRNA) that lacks the D stem. Surprisingly, our data show that the global
conformation and flexibility of the TLD does not change upon SmpB binding; however,
Mg2+ ions induce an 11 Å compaction of the TLD.
3.2 Materials and methods
3.2.1 RNA purification and fluorophore labeling. The RNA strands with 2’-protected
groups were purchased from the Keck Foundation Biotechnology Resource Laboratory
at Yale University School of Medicine (New Haven, CT). The deprotection reaction was
carried out according to the manufacturer’s protocol (Glen’s Research) as previously
described in the CHAPTER 2. Briefly, RNAs were dissolved in anhydrous dimethyl
sulfoxide (DMSO) and heated to 65°C for 2-3 hours. Then, triethyamine trihydrofluoride
was added, followed by desalting with 3 M sodium acetate pH 5.3 and butanol
precipitation (82). The pellets were washed with 100% ethanol and dried under speed
vacuum. In this project, the RNAs were constructed using two strands: A 5’-strand
containing the D loop, and a 3’-strand containing the T arm (sequences in Figure 3.2).
The 5’-strand contains fluorescein at its 5’-end and a 3’-amino linker used for
conjugation with tetramethylrhodamine (TAMRA) at its 3’-end. The location of the
fluorophores (top of acceptor stem and bottom of H2a helix) was chosen far from the
SmpB binding site (elbow region) to minimize the possibility of affecting SmpB binding.
The labeling of the 3’-end of the 5’-strands by TAMRA was accomplished as
previously described in the CHAPTER 2.
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Figure 3.2 Secondary structures of tmRNA and the fluorophore labeled
constructs. A. Secondary structure of tmRNA and location of the TLD and MLD.
Four pseudoknots (pk1, orange; pk2, blue; pk3, brown; pk4, pink) connect the
two major domains. B-D. Fluorescein (F) and tetramethylrhodamine (R) labeled
constructs for FRET studies: tmRNAΔ (B), tRNA∆ (C) and mtRNA∆ (D).
3.2.2 SmpB expression and purification. The smpB gene was cloned into pET21
plasmid to generate an encoding construct with a C-terminal histidine-tag. The gene
was transformed into E. coli BL21/DE3. Cells were grown at 37°C until the OD600nm
equals to 0.6. The cells then induced with 1 mM IPTG and incubated for an additional 3
hours. Lysis was done by sonicating the cells five times with 30 seconds pulses.
Between each pulse, 10 µl of 100 mM phenylmethanesulfonyl fluoride (PMSF) was
added, and the lysate was cooled down on ice for one minute before the next pulse.
Cell debris was removed by centrifugation at 6,000 g for 30 minutes. Cleared lysate was
heated at 65°C for 10 minutes followed by centrifugation at 6,000 g for 20 minutes. The
supernatant was applied to an IMAC column (Nickel column). After at least one hour
incubation of the supernatant with Nickel resin with rotation at 4°C, bound protein was
washed and eluted in (50 mM HEPES pH 7.5, 50 mM KCl, 50 mM MgCl2, and 2 mM
BME) supplement with 20 mM and 250 mM imidazole pH 7.5 respectively. SmpB purity
was confirmed by 12% sodium dodecyl sulfate gel (SDS gel). Pure fractions were
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dialyzed against storage buffer (20 mM NaCl, 10 mM Na2HPO4, pH 6.5) and stored at 20 C. protein concentration was determined by UV-VIS absorbance at 280 nm after
background subtraction (ε280nm = 22,900 M-1cm-1) (98).
3.2.3 Application of anisotropy in our system. Fluorescence anisotropy
measurements were performed using a spectrofluorometer with automated polarizers
(Varian, Cary Eclipse). Fluorescein-only labeled 5’-strand (25 nM) and 3’-strand (50
nM) was heated at 90˚C for 2 min and annealed >15 min at room temperature in
standard buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM MgCl2). Fluorescence
anisotropy was studied in the presence of the donor fluorophore only, because FRET
can result in decrease anisotropy, thus compromising our ability to interpret the results
(79-81). Measurements were performed at room temperature with RNA:protein ratios
varying from 1:0.0004 to 1:4. Fluorescein was excited at 490 nm (5 nm bandwidth).
Parallel ( ) and perpendicular (

) emission intensities were recorded at 520 nm (5

nm bandwidth). Fluorescence anisotropy was calculated as shown in the equation
(2.4) from the previous chapter.
The data were fit to the quadratic binding equation assuming 1:1 stoichiometry,

(3.1)

In which, r0 and rmax are the fluorescence anisotropies of fluorescein labeled
tmRNAΔ alone and bound to SmpB, respectively, KD is the dissociation constant,
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[RNA0] is the initial RNA concentration (25 nM) and [SmpB] is the total (free + bound)
SmpB concentration
3.2.3 Quantum yield calculation. The fluorescence quantum yield (QY) of fluorescein
attached to RNA constructs (Фx) was calculated using a standard fluorophore with a
known quantum yield (Figure 3.3). Here, we used free fluorescein in 0.1 M NaOH
aqueous solution as a reference (Фr 0.95 ± 0.03). The calculation of the fluorescein QY
in each construct was done according to the following equation:

(3.2)
Where, φX is the QY of the fluorescein attached to RNA, φr is the reference QY, Gradr
and Gradx are the gradients of integrated fluorescence intensity as function of
absorbance for reference (Figure 3.3) and sample (Figure 3.4) respectively. And η is
the refractive index of the solution.
R0 was calculated (see the equation (2.2) in CHAPTER 2) for RNA constructs after
recording of the absorbance spectrum of tetramethylrhodamine alone and linked to
RNAs (Figure 3.3).
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Figure 3.3 Reference gradient determination. A. Free fluorescein absorbance at
490 nm as a function of concentration in 0.1 M NaOH. As expected, absorbance
increases linearly as increasing concentration. B. Fluorescein integrated
fluorescence emission (Area) as a function of absorbance at 490 nm (A490). Area
was determined by integrating the recorded fluorescence emission spectrum with
excitation at the absorption maximum wavelength (490 nm). As expected, the
integrated fluorescence emission increases linearly with absorbance. References
gradient (Gradr) was calculated by fitting the results to the equation: Area =
(Gradr).A490 Confidence interval is the standard deviation from the fit.
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Figure 3.4 Gradient determinations. Fluorescein integrated fluorescence
emission (Area) as a function of absorbance at 490 nm (A490) for tmRNA (A),
tRNA (B) and mtRNA (C). The slope of a linear fit determines Gradx, which is
then used to calculate the fluorescein QY using the equation (2.8).
3.2.5 Steady State FRET applications. FRET measurements were carried out in a
Varian Cary Eclipse spectrofluorometer as described (82-84). Doubly labeled
(Fluorescein-TAMRA) 5’-strand (25 nM) and 3’-strand (50 nM) were heated and
annealed as described above. The experiments were performed at room temperature.
Fluorescein was excited at 490 nm (10 nm bandwidth) and fluorescence of the
fluorescein and TAMRA were collected between 500 nm and 650 nm (5 nm bandwidth).
The apparent FRET efficiency was calculated as follows:

(3.4)

In which, I520 is the fluorescence intensity at 520 nm (fluorescein peak) and I580 is the
fluorescence intensity at 580 nm (TAMRA peak). The SmpB concentration was varied
between 0.01 nM and 100 nM. For each measurement, the solution was manually
mixed and incubated for 5 minutes before recording.
3.2.6 Time-resolved FRET (trFRET) measurements. To determine the end-to-end
distance distribution of tmRNAΔ, we used trFRET, as described in the previous section.
A 250 nM solution of labeled 5’ strands (fluorescein-only or fluorescein-TAMRA labeled)
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and 500 nM of 3’ strand was heated and annealed as described above. Fluorescein was
excited at 490 nm (30 nm bandwidth dichroic filter) with an Yb-doped fiber laser (5 ps
pulses, 40 MHz). Donor emission was collected at 520 nm (20 nm bandwidth dichroic
filter) using a micro channel photomultiplier tube (R3890U-52, Hamamatsu) feeding a
time-correlated single photon counting card (SPC-630, Becker & Hickl) under magic
angle polarization (54.7°) to more than 40,000 peak counts. Fluorescence decays were
collected in 4816 channels with 12.2ps/channel time resolution. A dilute non-dairy
coffee creamer solution was used to measure the instrument response function. The
decay of the donor emission in the absence and the presence of the acceptor and with
and without SmpB was collected under identical conditions. The time-resolved for the
donor only complex was used to extract the three intrinsic parameters, donor lifetimes τi,
fractional contributions αi, and µi. The data from the doubly labeled tRNAΔs (IDA) were
then fitted according to the following equation:

,

(3.5)

In which, I0, is the initial intensity, τI and αi, are the singly labeled lifetime, and the
corresponding decay amplitude parameters respectively, P(R) is the distance
distribution, R0 is the Förster distance for 50 % energy transfer

(55 Å for the

fluorescein-TAMRA FRET pair). The distance distribution P(R) was analyzed as a threedimensional weighted Gaussian:
,

(3.6)

In which, N is a normalization constant, and σ and µ describe the shape of the
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Gaussian. An additional parameter was the fraction of singly labeled RNA since the
labeling reaction could not be 100% efficient. The ability to quantify multiple populations,
including singly labeled RNA, has been well established previously. This equation gives
information

about

the

mean

distance

between

the

fluorescein

and

tetramethylrhodamine, the distance distribution indicates the conformational flexibility of
the complex, and the fractional population provides information about the basis for the
thermodynamic analyses of conformational equilibrium (82, 86, 104-106). To test the
effect of SmpB and Mg2+ on the fluorescein quantum yield (QY), we measured the
average lifetime of fluorescein-only labeled tmRNAΔ under all conditions (3.26 ± 0.07 ns
in the absence of SmpB, 2.92 ± 0.15 ns in the presence of SmpB, 3.24 ± 0.16 ns in low
[Mg2+] and 3.19 ± 0.05 ns in high [Mg2+]). The data show that, within the standard
deviation, the fluorescein lifetime does not change, indicating the fluorescein QY
remains constant under our conditions.
3.3 Results
3.3.1 SmpB binds tmRNAΔ tightly and specifically. First, we sought to confirm that
SmpB efficiently binds the fluorophore-labeled tmRNAΔ construct using fluorescence
anisotropy. Fluorescence anisotropy is a dimensionless quantity (r) that measures the
rotation of a fluorophore. Low fluorescence anisotropies indicate that the fluorophore
tumbles freely in solution, whereas high anisotropies indicate that the rotation of the
fluorophore is hindered, for example by the formation of a large molecular weight
complex (80). In the absence of protein, the observed anisotropy value for tmRNAΔ
alone is low (0.06 ± 0.01). In the presence of 100 nM SmpB, the anisotropy increases
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to 0.15 ± 0.03, indicating that a larger molecular weight protein-RNA complex is
formed. A protein titration from 0.01 to 100 nM (Figure 3.5) shows that the observed
anisotropy values increase smoothly from 0.06 to 0.15. A fit to the quadratic equation
(see Materials and Methods) results in a dissociation constant KD of 1.0 ± 0.1 nM,
comparable to previously reported values (59). This result shows that SmpB binds
tightly to our fluorophore-labeled tmRNAΔ construct with one-to-one stoichiometry.
To test for the specificity of the protein binding, we repeated the experiments
using fluorophore-labeled alanyl tRNA (tRNAΔ) and mitochondrial seryl-tRNA
(mtRNAΔ), which are not expected to bind SmpB. The corresponding titrations show
that the fluorescence anisotropy of both RNAs remains low (0.07 ± 0.01) throughout
the protein concentration range, indicating that SmpB does not bind tRNA∆ or
mtRNA∆. These data are consistent with previous results that show that SmpB binds
tRNA with a 400-fold higher dissociation constant than tmRNA (59). Our data suggests
that only one SmpB binds the TLD, in agreement with prior studies, but in contradiction
with one other study that suggests that multiple SmpB molecules can bind the TLD
(107).
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Figure 3.5 SmpB binds tmRNA∆ tightly and specifically. Binding isotherms (50
mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM MgCl2) between SmpB and tmRNAΔ
(top), tRNA∆ (middle) and mtRNA∆ (bottom). Anisotropy increases indicate
SmpB binding to the RNA. Only tmRNA∆ binds SmpB, with a binding affinity, KD,
of 1.0 ± 0.1 nM within that concentration range.
Control anisotropy experiments by direct excitation of tetramethylrhodamine-labeled
tmRNAΔ (TAMRA-labeled tmRNAΔ) (Figure 3.6) confirm that the binding affinity
remains in the low nanomolar range and that neither the free amino linker nor TAMRA
affects binding of SmpB to tmRNAΔ.
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Overall, the fluorescence anisotropy data show that SmpB binds tmRNAΔ
tightly and specifically.

Figure 3.6 Free amino linker does not significantly affect SmpB binding.
Fluorescence anisotropy (r) of TAMRA on the doubly labeled tmRNA in standard
buffer conditions (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM MgCl2) as a
function of [SmpB]. Anisotropy increases with protein concentration indicating
binding. A fit to the quadratic equation (see Methods) yields a binding affinity, KD,
of 5.8 ± 2.5 nM. This result confirms that the binding affinity remains in the low
nanomolar range and that neither the free amino linker nor TAMRA affect SmpB
binding to tmRNA∆. The TAMRA anisotropy values for tRNA∆ and mtRNA∆
remain constant in absence (0.20 ± 0.03 and 0.19 ± 0.01, respectively) or in
presence of 100 nM SmpB (0.23 ± 0.02 and 0.18 ± 0.01, respectively). These
results confirm that SmpB binds tmRNA∆ tightly and specifically.
3.3.2 Mg2+ but not Na+ ions inhibit SmpB binding. We then sought to study the
effect of the monovalent and divalent cations on the tmRNA-SmpB binding. We
repeated the fluorescence anisotropy titration in 0, 1 and 10 mM Mg2+ concentrations,
and in the presence of 20 or 100 mM Na+. The Figure 3.7 shows the resulting SmpB
dissociation constants (KD) under these conditions. In the absence of Mg2+ and in 100
mM Na+, the dissociation constant is 0.4 ± 0.1 nM. Increasing the Mg2+ concentration
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to 1 and 10 mM increases the dissociation constant to 1.0 ± 0.1 nM and 2.6 ± 0.6 nM,
respectively. These results show that Mg2+ ions have an inhibitory effect on SmpB
binding.

Figure 3.7 Magnesium ions compete with SmpB binding.SmpB binding affinities
(KD) to tmRNAΔ as a function of Mg2+ and Na+ concentrations. Increasing Mg2+
concentration causes a decrease in the SmpB binding affinity. Decreasing Na+
concentration also decreases the SmpB binding affinity, and the Mg2+ effect
becomes less pronounced. Error bars stem from three independent
measurements.
When the sodium concentration decreases to 20 mM, the binding dissociation
constant ranges from 2.7 ± 1.0 nM (in the absence of Mg2+) to 11 ± 5 nM (in 10 mM
Mg2+), between four- and eight-fold higher than in 100 mM Na+. The fact that SmpB
binds better at the higher concentration of Na+ might be due to increased tmRNA∆
tertiary structure stability that in turn stabilizes SmpB binding. Regardless of the cause,
this result shows that the Mg2+ inhibition of SmpB binding is specific and not solely
electrostatic in nature. Overall, these results indicate that Mg2+ ions inhibit SmpB
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binding on tmRNAΔ and that high Na+ ion concentrations are required for tight SmpB
binding.
3.3.3 SmpB does not induce global conformational changes in tmRNA∆. To
monitor the global structure of tmRNA∆ upon SmpB binding, we used steady state
FRET (ss-FRET), which measures the apparent energy transfer efficiency from an
excited donor fluorophore to an acceptor fluorophore in close proximity. The apparent
FRET efficiency is extremely sensitive to the distance between the fluorophores in the
2-8 nanometer range, thus FRET measurements can be a valuable tool for probing
molecular structure and interactions (78). We placed the fluorophores fluorescein (F)
and tetramethylrhodamine (TAMRA) at the ends of the acceptor and helix H2a,
respectively to detect any conformational changes that would alter the angle between
the acceptor stem and the H2a arm. High FRET efficiency indicates that the two
fluorophores are in close proximity, and therefore, a more acute angle between the
helices, whereas low FRET efficiency indicates a longer distance between the two
fluorophores, and therefore, a more obtuse angle between the helices. In the absence
of SmpB, the observed apparent FRET efficiency is 0.23 ± 0.02 (Figure 3.8).
In the presence of 0.01 to 100 nM SmpB, the observed apparent FRET efficiency
remains approximately constant, indicating that the global tmRNA∆ conformation
remains unchanged. FRET can only report on the tmRNA∆ global conformation, and
therefore, our experiments cannot rule out local conformational changes at the binding
site of the protein. Control experiments with tRNAΔ and mtRNAΔ, which do not bind
SmpB, also show no changes in apparent FRET efficiency in the presence of 0.01 to
100 nM SmpB (Figure 3.8). Comparison of the observed FRET efficiencies reveals
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interesting structural differences between tmRNAΔ, tRNAΔ and mtRNAΔ. The lowest
observed apparent FRET efficiency (0.20 ± 0.02) corresponds to tRNAΔ, indicating that
it has the longest distance between the acceptor stem and anticodon stem. The highest
apparent FRET efficiency (0.28 ± 0.01) corresponds to mtRNAΔ, indicating that it has
the shortest distance between the acceptor stem and anticodon stem. The tmRNA∆
apparent FRET efficiency (0.23 ± 0.02) lies in between. Based on the crystal structure
and the TEB studies, one would expect tmRNA∆ to have lower apparent FRET
efficiency than tRNA∆, in apparent contradiction with these results. A possible
explanation is that the acceptor stem of tmRNA∆ rotates around its helical axis (relative
to tRNA∆) to bring the 5’-end closer to the H2a arm.
Steady-state FRET provides only an average apparent FRET efficiency and may
not detect the presence of minor populations in solution. To measure the distribution of
distances between the acceptor stem and helix H2a in the tmRNAΔ-SmpB complex, we
used time-resolved FRET (trFRET).
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Figure 3.8 The global structure of tmRNA∆ does not change upon SmpB
binding.Apparent FRET efficiencies for the flurophore labeled tmRNA∆ (A),
tRNA∆ (B) and mtRNA∆ (C) as a function of SmpB concentration. Error bars
stem from three independent measurements. Apparent FRET efficiencies remain
constant thorough out the titration range indicating that the global structure of
tmRNA∆ does not change upon binding. Control RNAs (tRNA∆ and mtRNA∆) are
not expected to bind SmpB.
Time-resolved FRET consists of measuring the fluorescence lifetime of the donor
fluorophore in absence and presence of the acceptor (Figure 3.9A, top panel). Energy
transfer from the excited donor to the acceptor results in an apparent decrease in the
donor fluorescence lifetime (compare black and green curves), which can be used to
determine the distribution of distances between the fluorophores (Figure 3.9, bottom
panel, green, Materials and Methods). In the absence of SmpB, the resulting distribution
for tmRNA∆ reveals a bimodal distribution. The major component (~70%, centered at 61
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± 1 Å) is assigned to the complex formed by the 5’ and 3’ strands, whereas the minor
component (~30%, centered at 32 ± 1 Å) is assigned to a hairpin RNA formed by the 5’strand alone. Control experiments in the absence of the 3’-strand (not shown), confirm
these assignments. The bimodal distribution is confirmed by the reduced Chi-square (χ2
≤ 1.2) compared to a single distribution fit (χ2 ≥ 1.4) (80, 85). In the presence of SmpB,
tmRNA∆ displays an almost identical distribution with a major component (~70%,
centered at 62 ± 1 Å), and a minor component (~30%, centered at 30 ± 1 Å). This result
confirms that the interaction between SmpB and tmRNA∆ does not change the distance
between the acceptor stem and the helix H2a of tmRNA∆.
We repeated the experiments with the canonical tRNA∆, which does not bind
SmpB (Figure 3.9). The resulting distributions (bottom panel) show that, in the absence
of SmpB (green), the major component is centered at 67 ± 1 Å, 5 Å longer than
tmRNA∆, in agreement with the ssFRET data. In the presence of SmpB (green), the
major distribution remains unchanged, as expected. Similar results were observed with
mtRNA∆ (Figure 3.9C), except that the distance between the acceptor stem and the
anticodon stem is ~4 Å shorter than tmRNA∆, in agreement with the ssFRET data
(Figure 3.5). Overall, these results show that SmpB does not change the overall
conformation of tmRNAΔ upon binding. A comparison of the results for tmRNA∆, tRNA∆
and mtRNA∆ reveals that, in 1 mM Mg2+, the distance distributions between the
acceptor stem and the helix H2a of tmRNA∆ lies between those observed for the control
RNAs.
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Figure 3.9 Donor fluorescence decays and resulting distance distributions.Top:
Donor fluorescence decays in absence (black) and in presence of acceptor (red),
and in presence of SmpB (green) for tmRNAΔ, tRNAΔ and mtRNAΔ, as
indicated. Bottom: Distance distributions calculated using Forster’s equation (see
Materials and Methods) in absence (red) and presence (green) of SmpB. Results
indicate that the global structure of tmRNA∆ does not change upon SmpB
binding.
3.3.4 Mg2+ ions compress the tmRNA∆ structure. To determine the effect of divalent
ions on the global conformation of tmRNA∆, we used trFRET to measure the distance
distributions from the acceptor stem to H2a between 0.1 mM and 100 mM Mg2+ ions
(Figure 3.10). In the absence of protein and in 0.1 mM Mg2+, the mean distance
between the two fluorophores is 63 ± 1 Å for tmRNAΔ (Figure 3.10A), two angstroms
longer than in 1 mM Mg2+. This distance decreases smoothly to reach 56 ± 1 Å above
10 mM Mg2+. A fit to the quadratic equation yields a dissociation constant KMg = 2.2 ±
0.6 mM.
In the presence of SmpB and 0.1 mM Mg2+, the distance between the two
fluorophores is 65 ± 1 Å, four angstroms longer than in 1 mM Mg2+. The distance also
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decreases with increasing magnesium concentrations to reach 56 ± 1 Å above 10 mM
(Figure 3.10B). A fit to the quadratic equation also results in a dissociation constant KMg
= 2.1 ± 0.2 mM. These results are within the experimental error of the distance
measured in the absence of SmpB, confirming that SmpB binding does not induce
global conformational changes in tmRNA∆ upon binding. This result seems in apparent
contradiction with our previous result showing that Mg2+ has an inhibitor effect on the
binding site of the protein (Figure 3.7); however, previous studies have shown that Mg2+
ions have multiple binding sites with different binding affinities on tRNA. Therefore, a
possible explanation for this result is that two distinct Mg2+ ions are involved: one that
has an inhibitor effect on the binding site of SmpB, while the other may bind inside the
elbow region and results in the structural compaction of tmRNA∆.
Unlike tmRNAΔ, the mean distance between the fluorophores in tRNAΔ remains
constant at 66 ± 1 Å at all magnesium concentrations above 0.1 mM, suggesting that all
Mg2+ ions are already tightly bound in the low concentration range. This is consistent
with previous studies that showed that magnesium can stabilize tRNA tertiary structure
in the micromolar range (108). The presence of SmpB does not change the observed
mean distance, as expected.
Mitochondrial mtRNAΔ behaves similar to tmRNA∆. In the absence of SmpB and
in low magnesium, the observed mean distance is 59 ± 1 Å, and this decreases slightly
to 56 ± 1 Å above 10 mM magnesium. A fit to the quadratic equation yields a
dissociation constant KMg = 0.7 ± 0.1 mM, in agreement with a previously reported
value. This result suggests that the observed compaction for tmRNA∆ and mtRNA∆
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may both be related to the absence of a D arm.

Figure 3.10 Magnesium ions compress the structure of tmRNA∆. DonorAcceptor distance measurement for tmRNAΔ(top), tRNA∆ (middle) and mtRNA∆
(bottom) in the absence (left) and presence (right) of saturating SmpB. A
distance decrease is observed for tmRNAΔ and mtRNA∆ with increasing Mg2+
concentration but not for tRNA∆. Error bars stem from three independent
measurements.
Overall, comparing the Mg2+ titration between tmRNAΔ, tRNAΔ and mtRNAΔ
suggests that the lack of a D stem (tmRNAΔ and mtRNAΔ) results in a low millimolar
affinity Mg2+ binding site that causes the distance between the acceptor stem and H2a
to decrease, but that does not compete for SmpB binding. Our data is in agreement with
TEB data that showed a more acute angle in the presence of magnesium than in the
absence of magnesium at 4ºC (101).
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3.4 Conclusions
Transfer-messenger RNA and SmpB are two of the key components in the
ribosome rescue system, and the interaction between these two molecules is
necessary for entry into the stalled ribosome (109). Previous studies have suggested
that SmpB mimics the anticodon loop of canonical tRNA, and binds to the decoding
center of the ribosome, whereas the helix H2a functions as a long variable arm of
class II tRNAs (103, 110). To determine the effect of SmpB and Mg2+ ion binding on
the structure and dynamics of tmRNA, we designed a fluorophore-labeled construct
(tmRNAΔ) that is very similar to the construct used in a previous crystallographic study
(102). The fluorescence anisotropy data confirms that SmpB binds tmRNA∆ tightly and
specifically. We then used steady state and time resolved FRET to monitor global
conformational changes that would alter the angle between the acceptor stem and
H2a of the tmRNA∆ upon interacting with SmpB. The results show no global
conformational changes upon SmpB binding, suggesting that the angle between the
acceptor step and H2a is more obtuse than that of canonical tRNAs, even in the
absence of SmpB.
To fit into the ribosomal A site, canonical tRNAs must have a fixed distance
between the decoding and the peptidyl transferase centers. But our trFRET
measurements show that, at saturating Mg2+ concentrations, the distance between the
acceptor stem and the helix H2a in tmRNA∆ is ~11 Å shorter than in tRNA∆ in spite of
the more obtuse angle (Fig. 3.10A). Although a larger distance may be expected for
tmRNA due to the more obtuse angle, this result can be explained by rotation of the
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acceptor stem around the helical axis that brings the two ends closer together.
Therefore, it seems unlikely that H2a of tmRNA functions as the equivalent of the anticodon stem in tRNA. This result is consistent with work from the Felden laboratory
(110) that shows SmpB induced protection of the conserved G530, A1492, and A1493
within the decoding center of the stalled ribosome. Furthermore, from the tmRNA
crystal structure, the distance between the acceptor stem and the C-terminal domain
of SmpB matches very closely the distance between the acceptor stem and the
anticodon stem of tRNA (103, 110, 111) (Fig. 3.11A).
Recent cryo-EM studies have shown a large conformational rearrangement
taking place in the tmRNA structure while the first MLD codon interacts with the A site
(Figure3.11B) (49, 112, 113). These studies show that during accommodation helix H2
and pk1 move together toward the intersubunit space, while pk2 remains in place. This
movement may assist in the placement of the region upstream of the open reading
frame in contact with SmpB to position the resume codon into the A site of the stalled
ribosome (49). The Mg2+-dependent conformational change observed here may
correspond to the rearrangement observed in the cryo-EM studies, suggesting that the
structure and flexibility of the H2 arm play an important role in tmRNA accommodation
and translocation, perhaps in positioning pk1 and the MLD as the TLD moves through
different sites in the ribosome. Altogether, our results may have interesting implications
for the mechanism by which tmRNA replaces the defective mRNA with its own MLD.
(Figure 3.11B).
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Figure 3.11 Distance comparison and tmRNA-SmpB model inside stalled
ribosome. (A) Measured distances between the acceptor stem and the anticodon stem in tRNA∆ and tmRNA∆ under saturating Mg2+. The ~10 Å shorter
distance in tmRNA∆ is consistent with the hypothesis that the H2a stem in
tmRNA does not function as an anti-codon stem mimic during trans-translation.
Based on the tmRNA-SmpB complex crystal structure, the distance between the
acceptor stem and the C-terminus of SmpB matches well with tRNA∆. (B) CryoEM studies reveal a large amplitude conformational change in tmRNA. The
image is generated using images of the TLD-SmpB in the accommodated (dark
blue PDB entry 3IZ4) and translocated states (light blue, PDB entry 3IYQ). Only
the tRNA-like domains are shown for clarity. The two structures were aligned
using SmpB as the reference. The arrow shows the conformational change
consistent with the Mg-induced compaction observed here.
In summary, we have used fluorescence anisotropy and FRET to characterize
the global structure of the TLD of tmRNA. Our results show that the global structure of
tmRNA remains unchanged upon SmpB binding. The distance between the acceptor
arm and the helix H2a is significantly shorter than in tRNA, consistent with a model of
trans-translation, in which the SmpB protein mimics the anti-codon stem of canonical
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tRNAs. Magnesium ions, however a 11 Å compression of tmRNA, which may help the
helix H2a bring the MLD near the ribosomal A site.
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CHAPTER 4
tRNAs Dynamics in Ribosomes
4.1 Introduction. Protein elongation is a dynamic process during which tRNA traverses
the ribosomal binding sites along a path of approximately 100 Å that requires large
structural rearrangements of the tRNA and ribosome (114). Translocation of tRNAs
through the ribosome involves large scale structural reorganization of tRNA-ribosome
interaction. Cryo-EM studies (115, 116), in addition to bulk and single-molecule
experiments (39, 44, 117) propose a counterclockwise rotation of the small ribosomal
subunit in respect to the large ribosomal subunit in a state referred as rotated or hybrid
state. This state has been suggested to be the substrate for EF-G catalyzed
translocation (118). Prior to translocation, deacylated tRNA bound to the P site
fluctuates spontaneously between classical (P/P) and hybrid (P/E) states in the pretranslocation (PRE) complex (44). During translocation, the hydrolysis of GTP leads to
translocation of mRNA-tRNA by one codon. A/A and P/P tRNAs pass through the hybrid
intermediate A/P and P/E states within a solvent-accessible channel formed by the
interface of large and small ribosomal subunits. Upon release of EF-G, the ribosome
returns to the non-rotated or classical conformation and the tRNAs move to the P/P and
E/E sites. Previous single-molecule FRET studies revealed the specificity of regulation
of the rate of PRE complex by a particular interaction between tRNA and the ribosome.
Recently, a single-molecule study suggested that the rate of transition between classical
and hybrid state dependent on the identity of tRNA (46).
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Although the tRNA contacts distinct binding sites within a solvent-accessible
channel when traversing the ribosome, it is not yet clear whether or not the environment
can affect the intrinsic dynamic of tRNA. To address this question, we have used single
molecule Protein Induced Fluorescence Enhancement (sm-PIFE) (119). Our data reveal
changes in the Cy3-labeled tRNA fluorescence intensity caused by change in the
fluorophore environment. We show that these changes are sensitive to the magnesium
concentration and the presence of antibiotics. We also observe two populations of tRNA
in the ribosome: a static one, in which the ribosome may be in the unlocked state, and a
dynamic one, in which the tRNA switches between different sub-states at constant rate.
These two populations are consistent with spontaneous ribosomal ratcheting.
4.2 Materials and Methods
4.2.1 Preparation of 70S ribosomes and mRNAs. The 70S ribosomal complex was
prepared from Escherichia coli MRE600 strain, as previously described in the
CHAPTER 2 (99). In summary, from overnight culture, the cells were grown in Luria
Broth (LB) media to mid-log phase and slowly cooled to 15°C. The pellets were
collected after centrifugation and resuspended in buffer A, then passed through a chilled
French Press using a 3/8” diameter piston and 18,000 psi pressure. After centrifugation,
the concentration of ammonium chloride was adjusted to 0.5 M, followed by
ultracentrifugation for 4 hours at 42,000 rpm speed. The pellets were resuspended in
buffer B (50 mM Tris-HCl pH 7.6, 0.5 M NH4Cl, 10 mM MgCl2 and 0.5 mM EDTA). The
crude 70S obtained were purified by sucrose density gradient followed by
ultracentrifugation for 17 hours at 42,000 rpm. The pellets were dissolved in ribosome
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storage buffer (10 mM Tris-HCl pH 7.5, 60 mM NH4Cl, 10 mM MgCl2), aliquoted and
flushed frozen in liquid Nitrogen. The aliquots were stored it at -80ºC.
Messengers RNAs (polyU and mRNA1, Figure 2.9) were designed from T7P10
gene, locus: Tag T7P10; location: (6475-7554). The constructs were purchased from
Keck Foundation Biotechnology Resource Laboratory at Yale University School of
Medicine (New Haven, CT). The RNAs were deprotected and gel purified as described
in CHAPTER 2.
4.2.2 Expression and purification of EF-Tu and EF-G. The plasmid pET9a containing
the six-histidine-tag EF-Tu or EF-G genes were obtained from Dr. Phil Cunningham,
Wayne State University. The genes were transformed into the E.coli BL21/DE3 strain.
After growing the cells in LB media with ampicillin-resistant to mid-log phase (OD600nm =
0.6) at 37°C, 250 rpm, the cells were induced with 1 mM IPTG for 3 to 4 hours. Lysis
was done in buffer B (50 mM Tris-HCl pH 8.0, 60 mM NH4Cl, 7 mM MgCl2, 7 mM 2mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 30 mM KCl, 10 mM
imidazole and 15% glycerol). The lysate was bound to a nickel column (IMAC column),
washed and eluted in the same conditions as the lysis buffer but at 20 and 250 mM
imidazole concentration respectively. Elongation factors purity was confirmed by 12%
sodium dodecyl sulfate gel (SDS gel). Pure fractions were dialyzed against storage
buffer (50 mM Tris-HCl pH 8.0, 60 mM NH4Cl, 7 mM MgCl2, 7 mM 2-mercaptoethanol,
30 mM KCl and 15% glycerol) and stored at - 20 C. protein concentration was
determined by UV-VIS absorbance at 280 nm after background subtraction (ε280nm(EF-Tu)
= 32,900 M-1cm-1, ε280nm(EF-G) = 62,200 M-1cm-1) (120).
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4.2.3 GTPase activity assay in the presence of 70S ribosome. To test the ribosomedependent GTPase activity of EF-G, the reaction was performed in Tris-polymix buffer
using 0.04 µM ribosome and different concentration of EF-G (0, 0.5, 1, 2.5, 5, 10 and 20
µM). Released of the free phosphate was measured using QuantiChromTM
ATPase/GTPase assay kit (DATG-200, Bioassay Systems) according to the
manufacturer's protocol. Briefly, phosphate standards were prepared by making dilution
series of phosphate (50, 30, 15 and 0 µM) in a total volume of 200 µl. The malachite
reagent was added, followed by 30 minutes incubation at room temperature. A dark
green color was detected due to the reaction of malachite green with the free phosphate
in solution. The OD at 620 nm was measured for each concentration and standard
curve was plotted of the OD620nm values as a function of phosphate concentration
(Figure 4.1) (121).

Figure 4.1 The optical density of malachite as a function of the release of
phosphate. The data show a linear relationship between the OD620nm of the
malachite and the release phosphate.
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To determine the GTPase activity of EF-G in the presence of the ribosome
(Figure 4.2), series of diluted concentrations of EF-G in the assay buffer were
performed in the absence (controls) and presence of 70S ribosome using 1 mM GTP.
The reaction was incubated for 10 minutes at 37°C, and then malachite green was
added to each reaction followed by further incubation at room temperature for 30
minutes. The OD620nm for each reaction was determined by using a microplate reader.
ΔOD620nm was calculated by subtracting OD620nm values of the reaction in the presence
of ribosome from those values in the absence of the ribosome (controls). The
concentration of liberated phosphate in each reaction was determined from the standard
curve.

Figure 4.2 GTPase activity in the presence of the ribosome. The amount of
released inorganic phosphate (Pi) in the reaction mixture is shown. This assay
was performed in the presence of the indicated amounts of E. coli EF-G. Amount
of released Pi in the absence of ribosome was subtracted from the background.
The EF-G activity was calculated according to the following equation:
Activity = [Pi] (µM) x 40 µL ÷ (10 µL x t) (U/L)

(4.1)

40 µL and 10 µL are the reaction volume and the EF-G volume in each reaction. t, is the
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reaction time (30 min). 1 unit of activity is the amount of EF-G that catalyzes the
production of 1 µmole of free phosphate per minute under the assay conditions.
4.2.4 tRNAs fluorophore labeling. The tRNAfMet and tRNAPhe were purchased from
Sigma. The initiator and elongator tRNAs were gel purified by 15% denaturing
polyacrylamide gel (PAGE) and then deacyled. The latter was done by incubating the
tRNAs separately in 100 mM Tris-HCl pH 8.0 at 37°C for 30 minutes followed by
phenol/chloroform extraction and isopropanol precipitation, dry vacuum and dissolve the
pellets in water. Labeling reaction of tRNAs by Cy3-maleimide for tRNAfMet or Cy3succimidylester for tRNAPhe at position 8 of 4-thiouridine (s4U8) and at 3-(3-amino-3carboxypropyl) uridine (acp3U47) respectively, was done following a previously
published protocol (122). Briefly, the Cy3-succimidylester (NHS) reaction with the
naturally modified base at position acp3U47 was performed by incubating 10 nmol of
tRNAPhe with 200 nmol Cy3-NHS ester in 75 ml labeling buffer (50 mM HEPES pH 8.0,
0.9 M NaCl) for 8 h at 30°C, followed by overnight incubation at 4°C (Figure 4.3). The
reaction of Cy3-malemide with s4U8 of tRNAfmet was done in 50 mM Tris-HCl pH 7.8 for
5 hours at 37°C. After quenching the labeling reactions with 1/10 of the total volume
with 3 M sodium acetate pH 5.5, the reactions were purified by phenol/chloroform
extraction, ethanol precipitation and C8-reverse-phase HPLC.
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Figure 4.3 Chemistry of the labeling reaction of the Cy3 succimidyl ester dye
with the primary aliphatic amino group of the 3-(3-amino-3- carboxypropyl)uridine (122).
The concentration of the labeled tRNAs was measured by using UV-VIS absorbance at
260 nm and 550 nm after background subtraction (78, 82).
4.2.5 Phenylalanyl tRNA synthetase (PheRS) expression and purification. The
E.coli XL1-BLUE strain, transformed with the ampicillin-resistant plasmid pQ31-FRS for
six-histidines E. coli pheRS expression was a gift from Dr. Michael Ibba laboratory, Ohio
State University. The cells were grown in LB media until the mid log phase. The cells
were then induced by 0.1 mM IPTG for 4 hours. The pellets were resuspended in the
PheRS lysis buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl and 5 mM Imidazole-HCl pH
8.0). After lysis and centrifugation at 7,000 g, 4°C for 20 minutes. The supernatant
passes through a Nickel column, washed and eluted by increasing the imidazole
concentration to 30 and 300 mM respectively (123).
4.2.5.1 Aminoacylation reaction. To perform this reaction, tRNAPhe has to be refolded
prior to the aminoacylation in the refolding buffer (30 mM HEPES pH 7.0, 30 mM KCl,
15 mm MgCl2) following a previously published protocol from the Unlenbeck laboratory
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(124). Briefly, the reaction was heated at 70ºC without magnesium. Then, it cooled to
65ºC and mixed with magnesium chloride to a final concentration of 15 mM. The tRNA
mixture was then incubated at room temperature for 30 minutes. Then an equal volume
of the amino acid mixture (250 µM L-phenylalanine in 30 mM HEPES pH 7.0, 30 mM
KCl, 15 mM MgCl2, 20 U/mL inorganic pyrophosphatase, 10 mM DTT and 8 mM ATP
and 2 µM of the pheRS) was added to the folded tRNAPhe and incubated at 37°C for 1
hour. This reaction is quenched with 1/10 volume of 3 M sodium acetate pH 5.2
followed by phenol/chloroform extraction and ethanol precipitation. The pellets were
then dissolved in ice-cold 10 mM potassium acetate (pH 5.0) to protect the labile
aminoacyl linkage, flash-frozen in liquid nitrogen, and stored at – 80ºC (125).
To test the activity of pheRS (Figure 4.4), the aminoacylation reaction was done
as described in the previous section, but instead of 250 µM of cold L-phenylalanine, 50
µCi of C-14 radiolabeled phenylalanine (1 µCi/µl) and 200 µM of cold L-phenylalanine
were added after the reaction was initiated by addition of pheRS and time points were
taken at 0, 5, 10, 20, 50, 70, 80, 85 and 90 minutes. The time points were stopped by
spotting a taken volume (1 µl) on TCA pads and immediately placing in TCA solution.
The TCA solution was exchanged three times, 15 minutes apart. The pads were then
washed with 100% ethanol for 5 minutes and dried under UV-lamp for 30 minutes. Each
pad was placed into a scintillation vial that contains 3 ml of scintillation fluid. After 1
hour, the vials were put in the scintillation counter.
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Figure 4.4 Activity assay of PheRS. Phenylation reaction reaches its upper limit
activity in less than 5 minutes as shown in the graph in which phe-tRNAphe
increases with time to reach the plateau in 5 minutes. To calculate the number of
pmoles of Phe-tRNAPhe formed, we used the following equation: Number of
pmoles = (time for each point time before starting incubation)*100/time of
maximum incubation).
4.2.5.2 N-acetylation reaction of Phe-tRNAPhe. The preparation of N-acetyl-PhetRNAphe was done as previously described (126). Briefly, 1.6 µM of Phe-tRNAPhe was
combined with 250 µl of cold 200 mM sodium acetate pH 5.2 and 4 µl of acetic
anhydride was added and incubated for 1 hour on ice. Another 4 µl of acetic anhydride
was added followed by another 1 hour on ice. The reaction is quenched with sodium
acetate pH 5.2 followed by phenol/chloroform extraction and ethanol precipitation. The
final product was dissolved in 2 mM sodium acetate pH 5.2, aliquoted, and stored at –
80ºC.
4.2.6 Characterization of tRNA species. To test whether or not we have different
species in the purified tRNAs that could result from missing some post-transcriptional
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modification of the tRNA. This problem could lead to misfolded states, which cannot be
detected by PAGE. To address this problem, we used two different techniques,
enzymatic footprinting and Matrix-assisted laser desorption ionization (MALDI). The first
technique can address the existence of multipopulations by different co migration on
PAGE. The second technique can clarify the site specific Cy3 labeled-tRNA.
4.2.6.1 Enzymatic footprinting. Enzymatic footprinting is one of the techniques that
have been used to map out different RNA structure or binding a ligand to nucleic acids.
The concept of the enzymatic digestion is based on digestion of a RNA by RNases
(here we used RNase T1, a fungal endonuclease that cleaves single-stranded RNA
after guanine residues (127)) followed by gel electrophoresis running and visualized the
bands after the gel exposure on the phosphoimager screen.
4.2.6.1.1 Dephosphorylation reaction. Fifty pmoles of tRNA were incubated in the
presence of Calf intestinal phosphatase (CIP) in CIP buffer (50 mM Tris-HCl pH 7.9,
100 mM NaCl, 10 mM MgCl2 and 1 mM dithiothreitol) at 50°C for 2 hours. The reaction
was quenched with 5 M NaCl followed by phenol/chloroform extraction and ethanol
precipitation (128).
4.2.6.1.2 Labeling the 5’-end of tRNA by [γ-32P] ATP and RNase T1 treatment. The
dephosphorylated tRNAs were incubated with T4-polynucleotide kinase in the kinase
buffer (70 mM Tris-HCl pH 7.6, 10 mM MgCl2 and 5 mM dithiothreitol) in the presence of
[γ-32P] ATP at 37°C for 45 minutes (128). The labeled tRNA was purified by 20%
denaturing PAGE (Figure 4.5), eluted using crush n’ soak method followed by
phenol/chloroform extraction and ethanol precipitation. Fifty thousand counts of the
radiolabeled tRNA were then treated with 0.5 U/µl of RNase T1 or 1 U/µl in 20 mM
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sodium citrate pH 5.0, 7 mM urea and 0.1 mM EDTA. The reaction was incubated at
55°C for 30 minutes and the bands were resolved on a 20% denaturing PAGE gel.
However, as shown (Figure 4.5C), we could not clearly resolve the long digested
fragment (Top bands in the gel of Figure 4.5C), we thought to use MALDI to address
this issue.

Figure 4.5 20% radiolabeled PAGE reveals pure tRNAs. A. Cy3-labeled and
unlabeled tRNAPhe show intense and moderate bands in each species. By
quantifying the two bands, the lower one represents ~ 20% for unlabeled
tRNAphe. In the Cy3-labeled tRNAPhe, the moderate band represents less than
10%. B. The radiolabeled tRNAfMet, both Cy3-labeled and unlabeled tRNA reveal
single band on the gel. C. Enzymatic footprinting of tRNAfMet in the presence of
different conditions: 1, Control reaction in the absence of RNase (RNA in water).
2, alkaline hydrolysis of the tRNAfMet (RNA in the presence of sodium hydroxide).
3, 4, 5,6, RNase T1 hydrolysis of the tRNA at different conditions; 3 and 4, in the
presence of 0.5 U/µL enzyme for 15 and 30 minutes incubation respectively. 5
and 6, in the presence of 1 U/µL enzyme for 15 and 30 minutes incubation
respectively.
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4.2.6.2 Matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS)
reveals the presence of the site modification on tRNAPhe. To verify the presence of
the post-transcriptional modified bases that helps the structure of tRNAPhe to fold
properly. Matrix assisted laser desorption/ionization mass spectrometry (MALDI) was
running after RNase T1 digestion of the tRNA. The E.coli tRNAPhe has the following
sequence:GCCCGGAS4UAGCUCAGDCGGDAGACCAGGGANUGAAEANCCCCGUm7
Gacp3UCCUUGGTNCGAUUCCGAGUCCGGGCACCA. The molecular weight of each
fragment was calculated by using (Mongo Oligo Mass Calculator v2.06) website. The
molecular weight of each fragment was verified by a Bruker Ultraflex TOF Alphacyanosinnapinic acid MALDI matrix (1mg) was resuspended in one milliliter of 50%
acetonitrile, 0.5% 3-hydroxypicolinic acid (HPA) and water. One µl of matrix was spotted
on a stainless steel MALDI plate followed by 1 µl of tRNA added on top of the matrix
and mixed with the matrix by pipetting up and down. This experiment was done for both
unlabeled and Cy3-label tRNAPhe. The problems that we faced in these experiments are
the high level of noise that rose probably from the presence of few tRNA materials in the
matrix. The results (Figure 4.6) reveal the presence of the modified base acp3U47 by
the presence of a peak with 2657.349 molecular weight compared to the molecular
weight of the (Um7GXCCUUGP, in which X = uridine (acp3U47)) where Cy3 can be
introduced (Figure 4.6 Top panel). Interestingly, we saw a peak nearby this peak that
has a molecular weight 2557.767 matches the molecular weight of the same fragment
(Um7GXCCUUGP, in which X = uridine). This data reveals that some of the tRNAPhe in
our experiment are not completely post-transcriptionaly modified at that position;
however, for the Cy3-labeled tRNA, we couldn’t properly resolve the peaks because of
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the high noise level; however, a peak with molecular weight 3320.316 that might
represent the Cy3-labed (Um7GXCCUUGP, in which X = uridine (acp3U47)).

Figure 4.6 MALDI results reveal the site specific labeling of tRNA by Cy3. A.
represents the MALDI spectra results of unlabeled tRNA reveals the presence of
probably two species, one is post-transcriptionally modified at position 47 and the
other one is not. B. represents the MALDI spectra of the labeled Cy3-tRNA that
show a peak that has molecular mass 3320.316 that might be related to the
fragment that has the Cy3 fluorophore.
4.2.7 Ternary complex formation. Cyanine 3 labeled tRNAfMet, tRNAPhe, or N-acetylPhe-tRNAPhe were complexed with EF-Tu(GTP) as previously described (16). This
complex are formed by incubating the GTP mixture in Tris-polymix buffer (10 mM GTP
in 50 mM Tris-HOAc pH 7.5, 100 mM KCl, 5 mM NH4Cl, 0.5 mM Ca(OAc)2, 15 mM
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Mg(OAc)2 and 6 mM BME) in the presence of 30 mM phosploenolpyruvate, and 12 U/ml
of pyruvate kinase. After addition of 12 µM EF-Tu, the mixture was incubated at 37ºC
for 15 minutes. Transfer RNA was added to a final concentration of 1.5 µM followed by
further incubation at 37ºC for 20 minutes.
4.2.8 Ribosome complexes. The 70S elongator complex was formed as previously
described (16, 36). In summary, the ribosome was incubated for 10 minutes at 37°C in
Tris-polymix buffer as mentioned above but with 5 mM instead of 15 mM magnesium
concentration followed by 5 minutes incubation when adding the mRNA. To fill the P site
of the ribosome with the deacylated-tRNA, the complex was mixed with the appropriate
ternary complex as described in the previous section followed by further incubation at
37°C for 20 minutes.
The 70S initiation complex was performed by incubating 1 µM 70S ribosome, 4
µM of biotinylated mRNA, 1.5 µM each of IF1, IF2, IF3 and tRNAfMet and 2 mM GTP in
Tris polymix buffer for 30 minutes at 37°C. To fill the A site of the ribosome, the complex
was mixed with N-acetyl-Phe-tRNAPhe followed by 1 hour incubation on ice. The final
concentration of the complex was 500 nM. The complex will be diluted to the picomolar
range in the single molecule imaging buffer (50 mM Tris-HOAc pH 7.5, 100 mM KCl, 5
mM NH4Cl, 0.5 mM Ca(OAc)2, 15 mM Mg(OAc)2, 6 mM BME, 5 mM putrescine, 1 mM
spermidine and 2 mM Trolox) for immobilization on the slide.
4.2.9 Antibiotics assays. Puromycin assay was performed as previously described
(36) with slight modification in the protocol. In summary, the PRE complex was
performed by filling the P site of the ribosome with deacylated tRNAfMet in complex with
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EF-Tu.GTP followed by 20 minutes incubation at 37°C to allow the complex to form. The
A site was filled with N-acetyl-Phe-tRNAPhe in complex with EF-Tu.GTP as described
(36). After the EF-G-dependent translocation (10 µM EF-G in the presence of 2 mM
GTP), antibiotic was added followed by 10 minutes incubation at 37°C. Experiments
with paromomycin and viomycin assays were done in the same way as puromycin
assay but without adding the translocation factor EF-G.
4.2.10 Single-molecule PIFE measurements. To observe PIFE in our system, we use
TIR (Total Internal Reflection) based single-molecule spectroscopy. This technique has
been commonly used to reduce the background signals by limiting the detection volume
to a thin sheet at the interface between a microscope slide and a solution. In this
technique, a laser beam (532 nm) reaches the quartz slide through a prism at an angle
slightly larger than the critical angle leading to total reflection of the beam. The Cy3
signals were collected using dichroic mirror and sent to a CCD camera. Data were
recorded at 33 milliseconds time resolution.
The mRNA in complex with the ribosome along with Cy3-labeled tRNA were
immobilized through a biotinylated DNA, which is hybridized to the first 15 nucleotides of
the mRNA sequence before the SD sequence, to the quartz slide by interaction with
streptavidin-coated PEG slide surface once the surface was passivated with a solution
of 10 µM of bovin serum albumin and 10 µM duplex DNA in order to prevent the nonspecific binding of the ribosome complex on the slide (Figure 4.7).
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Figure 4.7 Experimental set up. An mRNA/DNA hybrid is surface-immobilized
onto the quartz slide via biotin-streptavidin linkage. Cy3 labeled tRNAPhe or
tRNAfMet is shown bound to the P site of the ribosome. The fluorophore is excited
with a 532 nm laser by Total Internal Reflection Microscopy (TIRM). Emission
intensity is collected through the objective of an inverted microscope and
monitored by a CCD-camera.
4.2.10.1 Data analysis for PIFE. The single-molecule trajectories were analyzed using
a modified Matlab script to normalize the intensity of the fluorophore. Traces in which
the intensity of Cy3 remains constant were defined as static molecules and defined as
1.0 intensity. Traces in which the intensity of the fluorophore fluctuates among multiple
states were defined as dynamic molecules and the lowest intensity was defined as 1.0.
A cutoff of 1.3 normalized intensity was used to distinguish between two states. The
dwell time histograms for the dynamic molecules were fit to a single exponential to
determine k1 (rate constant of the molecules switching from state 1.0 to a higher
fluorescence) and k-1 (rate constant of the molecules switching from higher fluorescence
to 1.0). The fraction of static molecule at different EF-G, Mg2+, and antibiotic
concentration were fit to a modified Hill equation:
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(4.2)

In which, f0 is the initial fraction of molecules, fmax is the fraction of molecules at
saturating concentrations of EF-G or antibiotic, and Χ is the concentration of EF-G,
Mg2+, or antibiotic. KD is the dissociation constant.
4.3 Results
4.3.1 Fluorescence is only observed when all the components are present. To test
whether or not the system is working, and the fluorescence that we have seen is only
coming from our Cy3-labeled tRNA, control experiments were run by omitting one
component at a time (Figure 4.8). In the absence of the ribosome or tRNA, our data
showed no fluorescence. In the absence of mRNA, we saw very few spots that could be
related to non-specific binding of tRNA to the ribosome; however, in the presence of all
the components in the system, we can monitor the formation of the ternary complex at
the single-molecule level. The density of non-specific binding of tRNA was determined
by counting the number of seen spots in the single-molecule experiment in the absence
of mRNA. this number is divided by the surface of the rib (1458 µm2).
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Figure 4.8 In vitro translation system images.
inside the ribosome. The images in the absence
immobilized molecules. D. In the absence of
molecules, which might represent non-specific
ribosome.

A. The immobilization of tRNA
of 70S, or tRNA (B, C) show no
mRNA, the image shows few
binding (~8%) of tRNA to the

4.3.2 Sm-PIFE reveals two populations distribution of the PRE complex inside
ribosomes. Previous studies have showed spontaneous fluctuations of the PRE
translocated complex in the ribosome between classical and hybrid states (44, 46, 50).
These fluctuations are shifted toward the classical mode in the POST complex. To
further investigate the behavior of the P site tRNA as a fully functional system, singlemolecule protein-induced fluorescence intensity, sm-PIFE, was applied to the PRE
complex. Our data (Figure 4.9) shows two population distributions of the molecules: a
static population in which the molecules are motionless in one state and a dynamic
population in which the molecules fluctuate between sub-states. This distribution of
molecules varies in the absence or presence of GTP, GDP or the non-hydrolysable
GTP analog guanosine 5’-(β,γ-imido) triphosphate (GDPNP) Plotting the fraction of
static molecules as a function of different types of guanine phosphate (Figure 4.9C)
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shows ~ 45% of molecules are static in the absence of GTP or the presence of GDP.
This fraction increases to 67% in the presence of GDPNP and decreases to 18% in the
presence of GTP Interestingly, by plotting the rate constant of the dynamic molecules at
different conditions (Figure 4.9D) the data show no significant changes in the rate
constants under the experimental conditions that we used.

Figure 4.9 The fraction of static molecules depends on the presence or absence
of GTP, GDP or GDPNP with constant rate. A. Sm-PIFE time trajectories. The
dynamic population (top) is recognized by spontaneous fluctuations of the
fluorophore intensity between state 1 and state 2. The static population (bottom)
is recognized by static intensity in state 1. B. Histogram plotting shows the
distribution of 170 molecules in each population. C. The fraction of static state
variation in the absence or presence of GDP, GDPNP and GTP. D. Rate
constants of the dynamic molecules show no significant change as varying the
conditions.
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To investigate the origin of these populations, based on this result, we
hypothesized that the static population may represent the hybrid state and dynamic
population may represent the classical state. To test this hypothesis, EF-G.GDPNP and
antibiotics titrations were done. The data revealed a correlation between the population
distribution static and dynamic to hybrid and classical states respectively.
4.3.3 EF-G in the presence of non-hydrolysable GTP favors the static population
inside the ribosome. The successive movement of tRNA and mRNA through the
ribosome is catalyzed by a GTPase translational factor, EF-G. This factor allows
translocation of peptidyl-tRNA from the ribosomal A to P sites, exposing a new codon in
the A site for an incoming aa-tRNA (129). Previous studies have showed spontaneous
fluctuations of PRE complex in the absence of EF-G. This fluctuation is shifted toward
the hybrid state stabilization in the presence of EF-G and non-hydrolysable GTP. When
titrating the EF-G concentration (Figure 4.10) in the presence of initiator (tRNAfMet) or
elongator tRNA (tRNAPhe), the population distribution has an opposite effect. In the
absence of EF-G, the fraction of static molecules for tRNAfMet and tRNAPhe is 0.36 ±
0.05 and 0.45 ± 0.06 respectively. This fraction increases to 0.71 ± 0.03 and 0.75 ± 0.02
for tRNAfMet and tRNAPhe at 100 mM EF-G in the presence of 2 mM non-hydrolysable
GTP respectively (Figure 4.10, left panel). The fraction of static molecules increases
smoothly and by fitting the data to a modified Hill equation, gives a dissociation constant
KEF-G = 0.6 ± 0.2 µM for tRNAfMet, and KEF-G = 2.8 ± 1.2 µM for tRNAPhe. Interestingly, by
calculating the dwell time analysis of the dynamic population (Figure 4.10, right panel),
the rate constants do not change significantly across all the EF-G concentrations.
Comparing our results with a previously published data studying the ratcheting and the
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hybrid state during translocation, our static state might correspond to the state that can
be stabilized by the presence of stabilized EF-G.GDPNP, which is the hybrid state.

.
Figure 4.10 EF-G.GDPNP shifts the spontaneous fluctuation equilibrium of tRNA
toward static population without affecting the rate constants of the dynamic
molecules. Left panel. The fraction of static molecules fs increases as a function
of EF.G concentration for tRNAfMet (top panel), and tRNAPhe (bottom panel). The
data were fitting to a modified Hill equation (see Materials and Methods section)
to calculate the KEF-G. Right panel. Rate constants of the dynamic molecules for
tRNAfMet (top panel), and tRNAPhe (bottom panel) show no significant changes as
increasing the EF-G concentration.
4.3.3 Mg2+ alters the dynamics of tRNA in the ribosome. Previous single-molecule
experiments have found a sensitivity of the dynamic equilibrium in the PRE complex to
the Mg2+ concentration. It has been shown that low Mg2+ concentration shifts the
dynamic equilibrium of the PRE complex toward the hybrid state motion; however, high
Mg2+ concentrations favor the classical state over the hybrid state. To further examine
the effect of Mg2+ in our study, we repeated the sm-PIFE experiments at different Mg2+
concentration (Figure 4.11). At 3.5 mM Mg2+, the fraction of static molecules is 0.62 ±
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0.02. Increasing the Mg2+ concentration to 15 and 30 mM decreases the fraction of
static molecules to 0.45 ± 0.03 and 0.44± 0.02 respectively. A fit to a modified Hill
equation (see Materials and methods) gives a dissociation constant KMg of 5.9 ± 0.4
mM. This result supports previous single-molecule experiments, and agrees with the
hypothesis that the one state motion that we have seen may correlate to the hybrid
state.

Figure 4.11 Mg2+effect on the fraction of static molecules. Top panel represents
the fraction of static molecules as a function of Mg2+. fs decrease as increasing
the concentration of Mg2+. KMg was calculated by fitting the data to a modified Hill
equation. Bottom panel represents the rate constants of the dynamic molecules;
the data reveals that k1 and k-1 are independent of Mg2+ concentration.
4.3.6 Puromycin binding increases the fraction of static molecules. Puromycin, an
analog of the 3’-end of aminoacyl-tRNA, binds weakly to the large ribosomal subunit
near the A site via interaction with the A loop and reacts rapidly with the nascent chain
when it resides in the P site. Previous single-molecule experiments revealed a
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stabilization of the tRNA in its hybrid state in the presence of saturated concentration of
puromycin. To further investigate the dynamic properties of tRNA, we performed a
puromycin titration. Without puromycin, the fraction of static molecules is 0.36 ± 0.03.
At 100 mM puromycin, this fraction increases to 0.80 ± 0.03. An antibiotic titration from
0.1 to 100 mM (Figure 4.12, top left panel) shows that the fraction of static molecules
increases smoothly from 0.36 to 0.80. A fit to a modified Hill equation results in a
dissociation constant Kpur = 0.56 ± 0.16 mM. Plotting the rate constants of the dynamic
molecules versus puromycin concentration (Figure 4.12, bottom left panel), the data
showed no significant changes in the rate constants with the antibiotic.
4.3.5 Viomycin shifts the dynamic of tRNA toward static motion. Viomycin has
known to bind the intersubunit B2a region of the ribosome and strengthens the
association of ribosomal subunits. Viomycin may inhibit translocation by hindering the
ratcheting of the ribosomal subunits and trapping the PRE complex in its hybrid state.
To test the effect of viomycin on the fluorescence of Cy3-labeled tRNA, we performed a
viomycin titration (Figure 4.12, middle panel); the results reveal a smooth increase in
the fraction of static molecule with increasing viomycin concentration. Without viomycin,
the fraction of static molecules is 0.45 ± 0.04, at 10 mM viomycin, this fraction increases
to 0.69 ± 0.03. Fitting to a modified Hill equation gives a Kvio = 0.11 ± 0.03 mM. Our data
suggest that viomycin can mostly trap the PRE complex in one state probably by locking
the ribosome in a conformation that stabilizes static motion. Our results combined with
previously published data, suggest that the static is the hybrid state in which the
ribosome is ratcheted.
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4.3.6 Paromomycin binding shifts the dynamic equilibrium of tRNA toward
multistate motion. Paromomycin is an aminoglycoside antibiotic, known to alter the
dynamic of the PRE complex by stabilizing the classical state. Previous single-molecule
experiments from the Blanchard laboratory have suggested an increase in the fraction
of tRNA in the classical state by 2% at satured paromomycin concentration (20 µM). To
investigate the effect of this antibiotic on our experiments, sm-PIFE was applied. The
data (Figure 4.12, right panel) shows a decrease in the fraction of static molecules
with increasing the concentrations of paromomycin. A fit to a modified Hill equation
gives Kpar = 0.48 ± 0.06 µM.

Figure 4.12 Antibiotics disrupt the dynamic equilibrium of the tRNA. Right panel
shows the effect of puromycin on the fraction of static molecules. fs increases
with the presence of puromycin. The rate constants of the dynamic molecules are
insensitive to the presence of the antibiotic. Middle panel represents the viomycin
effect on the dynamic of tRNA. As in the presence of puromycin, fs increase
smoothly as increasing the viomycin concentration. The rate constants of the
dynamic molecules remain constant. Left panel reveals the effect of
paromomycin of the fs that decreases as increasing the antibiotic concentration.
The rate constants have no significant change by increasing the antibiotic
concentration. Kpur, Kvio, and Kpar were calculated by fitting the data to a modified
Hill equation (see Materials and Methods).
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4.3.7 Characterization of binding of deacylated tRNA to the ribosome. It has been
reported that at high Mg2+ concentrations (> 10 mM) and in the presence of high
tRNAphe concentrations in polyU-programmed ribosomes, a deacylated tRNAPhe can
occupy the three ribosomal binding sites P, E and A sites respectively. To address the
possibility of the presence of multiples tRNAPhe in our system, we performed a tRNAPhe
titration. The data (Figure 4.13) show no significant change in the fraction of static
states across all tRNAPhe concentrations.

Figure 4.13 Fraction of static molecules variation as a function of tRNAPhe
concentration. The fraction of static molecule does not have any significant
change as varying the tRNA concentration.
4.4 Conclusions
4.4.1 Spontaneous fluctuation of PRE translocation complex is a multistep
process. By applying single molecule PIFE, we have shown that the PRE translocation
complex can be classified into two populations: a static state population where the
intensity of tRNA labeled Cy3 is motionless and a dynamic population where the

96

intensity of the fluorophore fluctuates among different sub-states. The dynamic
equilibrium between these two populations is dependent on the identity of tRNA in the P
site. For the initiator tRNA, the dynamic equilibrium is shifted toward multistate motion
(~65%); however, for the elongator tRNA (tRNAPhe), this equilibrium is more evenly
divided between static (~45%) and dynamic (~ 55%) molecules. Our data are consistent
with previous sm-FRET data that have showed spontaneous fluctuation of tRNA in a
PRE complex between classical and hybrid state, and the importance of the identity of
the tRNA in the P site on the equilibrium between these two states. However, the
advantage of sm-PIFE is its sensitivity to small changes that could occur in a distance
smaller than 3 Å. The sensitivity of sm-PIFE allows us to see fluctuation in the
fluorophore intensity within the one state. Since the dynamic equilibrium between static
and dynamic populations can be shifted by changing the EF-G concentration, the
observed fluctuation in the intensity of Cy3 is unlikely to be a photophysical artifact of
the fluorophore. Besides, we have chosen to label the tRNA at different positions
(position 8 of 4-thiouridine (s4U8) for tRNAfMet and position 3-(3-amino-3-carboxypropyl)
uridine (acp3U47) for tRNAPhe to exclude the possibility of the effect of the labeling
position on the intensity of Cy3. Our results at different EF-G concentrations are
consistent with previously published data about tRNA fluctuation. The data suggest that
the static state population might represent the hybrid state, and the dynamic population
might represent the classical state. Interestingly, our dwell time analysis of the dynamic
molecules reveals that the rate constants of fluctuation among sub-states are
independent of EF-G concentration. These data suggest that within the ribosomal A or
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P sites, tRNA is highly dynamic, but the hybrid state makes the tRNA more rigid,
resulting in static PIFE (Figure 4.14A).
4.4.2 Mg2+ may stabilize tRNA-ribosome interactions. Previous work has shown that
tRNA and the ribosome form multiple contacts in the PRE complex, such as mRNAtRNA interaction through the codon-anticodon, interaction of the codon-anticodon stem
loop with the rRNA components h44 and h18 as well as interaction of the rRNA H38
and the protein L16 with the elbow region of tRNA; however, by unlocking the ribosome
during translocation, these interactions have to be weaken, then restored back after
translocation. Mg2+ stabilizes the formation of RNA tertiary structure in addition to its
role in electrostatic screening and tertiary interaction. Moreover, previous singlemolecule experiments have found a sensitivity of the dynamic equilibrium in the PRE
translocation complex to the Mg2+ concentration. It has been shown that low Mg2+
concentrations favor the hybrid state; however, high Mg2+ concentrations favor the
classical state. Our experiments have revealed decrease in the fraction of static
molecules by approximately 20% at high Mg2+ concentrations. The data combined with
previously published single-molecule data suggest that Mg2+ may have a role in
stabilization of tRNA-ribosome interaction in the classical state. Thus it can hinder the
movement of tRNA with respect to the ribosome to its hybrid state or reduce the
unlocking events during ratcheting.
4.4.3 Evidence of the relation between ribosome ratcheting and fluorescence
fluctuation. In addition to its sensitivity to Mg2+, previous studies have revealed that
tRNA dynamics within the PRE complex are sensitive to drugs known as translocation
inhibitors antibiotics, such as viomycin, thiostrepton, aminoglycosides, and so on. Some
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of these antibiotics are related structurally to clinically compound targeting ribosome to
treat infections. Here, we demonstrate through single-molecule PIFE that tRNA in the
PRE complex is mostly dynamic. Comparing our data with previously published data
studying the dynamic of the PRE complex, the comparison reveals a consistent relation
between our finding and ribosome ratcheting, in which our static population is consistent
with hybrid state motion; however, the dynamic population is consistent with classical
state. A model is proposed (Figure 4.14) to summarize the effect of paromomycin and
viomycin on the PRE complex dynamic. In this model, paromomycin binds to the
conserved decoding region in the A site of the ribosome. This binding enhances the
stability of tRNA-A site interaction, and inhibits the translocation of tRNA to the P site.
This effect is interpreted by stabilization of the PRE complex dynamic in its multistate
motion or classical state. On the other hand, viomycin, which has been used extensively
in translocation studies, yet, there are merged results about whatever the viomycin
stabilizes the classical or hybrid states. Bulk and some single molecules studies probing
the intersubunits ratcheting suggested that viomycin stabilizes the P/E hybrid state,
however, a previous single-molecule study by Puglisi and coworkers probing the tRNAtRNA distances suggested that viomycin favored the classical state conformations of
tRNA. A recent single molecule study by Blanchard and coworkers has revealed that
the viomycin may trap the hybrid state within subgroups but didn’t significantly suppress
the dynamic of tRNA. Blanchard, in his study, suggested that viomycin revealed a
bimodal behavior; however, at viomycin concentration more than 100 µM, viomycin
stabilized the hybrid state by 12%. By modeling the viomycin effect on the translocation
(Figure. 4.14B) the binding of this drug to the intersubunits binding site, viomycin might
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stabilize the ribosome dynamic in one state, which is according to our data is the one
state motion or hybrid state.

Figure 4.14 Model summarizing the effect of antibiotic on the PRE complex
dynamic. In the absence of antibiotics, tRNA fluctuates spontaneously between
classical and hybrid states. Adding of EF-G.GDPNP, the equilibrium is shifted
toward one state motion (hybrid state). In the presence of antibiotics, our data
show that paromomycin shifts the equilibrium of spontaneous fluctuation of tRNA
to the classical state; however, viomycin may lock tRNA in its hybrid state (41).
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CHAPTER 5
Monitoring the Entrance of the tmRNA-SmpB Complex into Stalled Ribosomes
Using Sm-FRET
5.1 Introduction. The trans-translation system is known to recycle stalled ribosomes on
defective mRNAs, and degrade the incompletely synthesized protein by adding a Cterminal tag as a degradation signal for cellular proteases. Therefore, the defective
mRNA can be targeted by RNases (130).
Trans-translation has two main components; tmRNA, a hybrid molecule that has
a bifunctional property as tRNA and mRNA (130, 131). A crystal structure from the Ban
laboratory suggested that SmpB binds to the elbow region of the TLD in tmRNA (102).
Another crystal structure from the Yokoyama’s laboratory supported this finding.
Superimposing the crystal structure of the TLD-SmpB complex and the canonical tRNA
suggests that SmpB mimics the lower part of the canonical tRNA, which is the
anticodon stem-loop, raising the possibility that SmpB binds around the decoding center
during trans-translation (103). This view was supported by a cryo-EM study of the
quaternary complex (tmRNA.SmpB.EF-Tu.GDP) in the presence of Kirromycin (18) and
confirmed by a recent crystal structure of the TLD-SmpB complex inside the ribosome
(71). Although there is no sufficient information about the structure and the exact
location of the C-terminal tail in the full tmRNA-SmpB complex inside the ribosome, it
has been shown that truncation of this part from SmpB leads to loss of the transtranslation process (132). Directed hydroxyl probing study by the Himeno laboratory has

101

suggested two SmpB binding sites in the ribosome, one at the A site and the other at
the P site. In both sites SmpB occupies the location of the anticodon arm of canonical
tRNA. It has been suggested that the first residue of C-terminal tail, residue number 133
that is located near the decoding center and the residues 150 and 153 of SmpB are
near the helices 16 and 18. Thus the C-terminal tail of SmpB may lie along the mRNA
path towards the downstream tunnel. Probing experiments with the Fe (II) tethered to
the residues 152 and 155 of P site SmpB cleaved three portions of 16S rRNA, 1231 and
1382–1385, all around the site of the codon–anticodon interaction in the P site. From
their study, the authors hypothesized that the C-terminal domain of SmpB in the A site
mimics mRNA; however, in the P site, this domain is located around the region of the
codon-anticodon interaction (132, 133).
The goal of this part of the dissertation is to study the entrance and
accommodation of the tmRNA-SmpB-EF-Tu complex into the ribosome by sm-FRET.
Based on previous studies on cognate tRNA accommodation (16, 17), we hypothesized
that the accommodation of tmRNA inside a stalled ribosome is multistep process as
well. To test this hypothesis, we have used sm-FRET (Figure 5.1) designing a labeling
approach; a FRET donor on the P site Phe-tRNAPhe and a FRET acceptor on the SmpB
protein. A polyuridine (polyU) mRNA missing a stop codon was designed as the
defective mRNA (short strand 1 and 2 in Figure 2.9, CHAPTER 2). Measuring the
FRET efficiency between the two fluorophores allowed us to monitor the
accommodation of the tmRNA into a stalled ribosome. Intermediates states in this
pathway were identified using non-hydrolysable GTP and antibiotics.
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Figure 5.1 Single-molecule FRET set-up. The mRNA/DNA hybrid is surfaceimmobilized onto the quartz slide via biotin-streptavidin linkage. Cy3 labeled PhetRNAPhe is shown bound to the P site of the ribosome. The quaternary complex
(tmRNA.SmpB.EF-Tu.GTP) with a Cy5-labeled SmpB is introduced in the flow
cell. The donor is excited with a 532 nm laser by Total Internal Reflection
Microscopy (TIR). Emission Intensities of the donor and acceptor are collected
through the objective of an inverted microscope and monitored by a CCDcamera.
Single-molecule FRET data allowed the observation of three different FRET states. We
proposed that the low FRET state may correspond to the initial binding of the
quaternary complex to the ribosome, mid FRET state may represent the preaccommodated state and high FRET state that may correspond to the fully
accommodated state of tmRNA.
5.2 Materials and methods
5.2.1 In vivo and in vitro transcription of tmRNA. The modified plasmid (pET28 BA)
containing the ssrA and SmpB genes was a gift from Dr. Karzai, Stony Brook, NY. The
plasmid was sequenced, and then transformed in BL21 competent cells. Cells were
grown to mid log phase (OD600nm = 0.5). Lysis, washing and elution were done following
the same procedure used for SmpB purification (Materials and methods, CHAPTER 3).
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The tmRNA was separated from the SmpB protein following a protocol from the Karzai
laboratory (98). In summary, the separation of the tmRNA-SmpB complex was done by
extracting tmRNA with TRI-reagent LS in the presence of 1-bromo-3-chloropropane
following the manufacturer’s instructions. A (3:1) ratio of TRI-reagent LS and tmRNASmpB complex was incubated for 5 minutes at 25°C to allow a complete dissociation of
the complex. This step is followed by the addition of the bromo-3-chloropropane to the
mixture, vortex and centrifuge at high speed and 15 minutes incubation at room
temperature followed by centrifugation for 15 minutes at 12,000g at 4°C. The upper
phase, in which the tmRNA is present, was extracted twice followed by isopropanol
precipitation. This step was followed by further purification of tmRNA using FPLC
MonoQ (HR10/10) anion exchange column. Fractions containing tmRNA were collected
and a 1/10 volume of 3 M sodium acetate pH 5.0 was added followed by isopropanol
precipitation. The tmRNA-containing pellets were washed with 75% ethanol and
resuspended in autoclaved water and stored at -20°C. (Figure 5.2) (98, 134).
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75 KDa

tmRNA‐SmpB
20 KDa
11KDa

Figure 5.2 The main purification steps of the native tmRNA. Upper panel
represents a 12% SDS-gel that reveals a pure protein in the tmRNA-SmpB
complex. Lower panel represents the FPLC result of the tmRNA after disrupting
the RNA-protein complex. Each fraction is collected and concentrated using
cutoff filter membrane.
Transfer-messenger RNA can be also generated by in vitro transcription using
the Ambion MEGshortscript T7 transcription kit. A PCR product was first generated with
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T7 promoter using the following forward GAAATTAATACGACTCACTATAGGGGCTGA
TTCTGGATTCGACGG and reverse TGGTGGAGCTGGCGGGAGTTGAACC primers
(111). The product was gel-purified, phenol/chloroform extracted and ethanol
precipitated. The pellets were resuspended in water. This PCR extension product is
used as template for the transcription reaction that was accomplished at 37°C for 4
hours. All reagents except the template and the primers were provided by the kit. After
incubation, TURBO DNase (from kit) was added. This step was followed by further 15
minutes incubation at 37°C. The reaction was passed through NAP-10 columns
(sephadex columns) to remove excess NTPs then quenched with sodium acetate,
phenol/chloroform extracted and ethanol precipitated. The pellets were resuspended in
the tmRNA refolding buffer (10 mM Tris, pH 7.5, 5 mM MgCl2, 20 mM NH4Cl). The
refolding process was done by heating the tmRNA at 75°C for 3 minutes followed by
slowly cooled down to the room temperature for 30 minutes to one hour. The
quantification of tmRNA was done by measuring the OD260nm (εtmRNA= 3577000
M−1·cm−1).
5.2.2 SmpB mutation. To study the entrance and the accommodation of tmRNA by smFRET, a FRET donor Cy3 was attached to the tRNA in the P site of the ribosome and a
FRET acceptor Cy5 on SmpB. Thermus thermophilus SmpB has no cysteine residue in
its sequence (65). For this reason, a mutation of alanine by cysteine at position 67 was
designed since this position does not affect the binding of SmpB to tmRNA and the
ribosome. The mutation was done using a Quick Change Site-Directed Mutagenesis Kit
with the following primers: Forward primer: 5’- GCT CTA CAA CCT CTA CAT ATG CCC
GTA TAA ACA CGC GAC-3’ and reverse primer: 5’- GTC GCG TGT TTA TAC GGG
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CAT ATG TAG AGG TTG TAG AGC- 3’. The bolded nucleotides are the mutant codon
in which the cysteine will be replaced by alanine. The mutation was done following the
manufacturer's protocol. The expression and purification was done following the same
procedure as in (Materials and methods, CHAPTER 3). To test whether or not this
mutant protein binds to the TLD of tmRNA, an anisotropy experiment was done as in
Materials and methods, CHAPTER 3. The result (Figure 5.3) reveals an affinity of
binding in the same range as the wild type SmpB.

Figure 5.3 Mutant SmpB binds TLD tightly. Binding isotherms (50 mM Tris-HCl
pH 7.5, 100 mM NaCl, 1 mM MgCl2) between SmpB and the TLD of tmRNA.
Anisotropy increases indicating the binding of this protein to the RNA. Plotting the
data to the quadratic equation (Materials and methods, CHAPTER 3) reveals a
binding affinity KD = 2.6 ± 0.9 nM comparable with the wild type SmpB (KD = 1.0
± 0.1 nM).
When applying sm-FRET, a great amount of crashing was seen on the
PEGylated slide; the presence of this protein is a possible reason; however, trying
different concentrations of this protein did not resolve the crashing problem. We next
thought that tmRNA and the mutant SmpB are not content as a complex since these
two components are from different organisms. For this purpose, we got the plasmid that
has a mutant E.coli SmpB from the Himeno laboratory. After transformation of the
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plasmid in BL21 cells, the mutant SmpB was expressed and purified following the same
procedure as before. The binding of this SmpB to the tmRNA was tested by anisotropy
as describing in CHAPTER 3, Materials and methods.
5.2.3 Labeling of SmpB by Cy5 acceptor fluorophore. The labeling reaction of the
protein by an acceptor fluorophore (Cy5) is preceded by incubation of the protein with
10 mM dithiothreitol (DTT) for at least 1 hour in ice to reduce any S-S bond that could
affect the labeling efficiency. This step is followed by exchange of the SmpB storage
buffer with the labeling buffer (50 mM Tris-Cl pH 7.0, 120 µM TCEP (tris (2-carboxyethyl) phosphine)) using a Bio-spin 6 tris column. After equilibration of the column with
the labeling buffer, the protein passes through the column by centrifugation at 900 rcf
for 3 minutes. The labeling reaction was accomplished by mixing of 30-35 µM of the
protein with 10 µl of the Cy5 dye (200 mg of the solid dye was dissolved in 100 µl of
DMSO, vortex to dissolve) followed by reaction under Argon for one hour at room
temperature in a dark place. After incubation, the protein was passed through the Biospin 6 tris column to separate the labeled SmpB from the free dye. The UV-Vis
absorbance at 280 nm, and 650 nm was taken before and after labeling for comparison
and determination of the labeling efficiency (Figure 5.4).
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Figure 5.4 Absorbance spectrum for unlabeled and labeled Cy5-labeled SmpB.
Top panel represents the spectrum of unlabeled SmpB revealing a single peak at
280 nm. Low panel represents the spectrum of labeled SmpB that shows two
peaks, one at 280 nm (protein) and the other at 650 nm (Cy5). The absorbance
was recorded by nanodrop.
5.2.4 Alanyl-tRNA synthetase (AlaRS) expression and purification. The plasmid
pET20b containing the AlaRS gene was a gift from Dr. Paul Schimmel, the Scripps
Research Institute California. The plasmid was sequenced followed by transformation in
BL21 cells, expressed and purified by using a nickel column in the last step following a
previously published protocol (135). Briefly, after growing to the mid log phase, the cells
were lysed by sonication in the lysis buffer (25 mM Tris-HCl pH 8.0, 500 mM NaCl, 10
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mM β-mercaptoethanol and 15 mM imidazole). This step was followed by centrifugation
at 6,000 g for 20 minutes. The supernatant was loaded on the nickel resin, incubated for
at least 1 hour with the resin at 4°C. The supernatant was washed and eluted by
increasing the imidazole concentration to 20 and 250 mM respectively. The fractions
were collected and concentrated using a cutoff filter column, followed by dialysis
overnight (135).
5.2.4.1 Alanylation reaction. To ensure that tmRNA is folded properly, a refolding
process was done by incubating the tmRNA in water bath at 80 °C for 5 minutes then
allowed 30 minutes incubation at room temperature. The alanylation reaction was
accomplished in 101 buffer (20 mM Tris-HCl pH 7.5, 20 mM MgCl2, 1 mM DTT, 2 mM
ATP, 250 µM L-alanine). Five micromolar of tmRNA was added in addition to (1:10)
volume ration of AlaRS:tmRNA. The reaction was incubated at 37 °C for 30-60 minutes,
quenched with 1/10 volume of sodium acetate pH 5.0, phenol/chloroform extracted and
ethanol precipitated. The alanyl-tmRNA pellets obtained were resuspended in 20 mM
potassium acetate pH 5.1 (111).
To test the activity of AlaRS, we repeated the alanylation reaction described
above but adding 15 µM of hot alanine (isotopically radiolabeled with

14

C-alanine) and

200 µM of cold L-alanine instead of 250 µM L-alanine listed above. After incubation for
30-60 minutes at 37°C, One microliter from the reaction was taken and spotted for
counting before and after the reaction was accomplished. The rest of the volume was
quenched with sodium acetate pH 5.0, phenol/chloroform extracted and ethanol
precipited. The pellets were resuspended in 20 mM KOAc, pH 5.1.
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5.2.5 The quaternary complex formation. The formation of the Ala-tmRNA-SmpB-EFTu.GTP complex is an essential step to deliver the tmRNA into a stalled ribosome. This
step is accomplished in 219 buffer (50 mM Tris-HCl, pH 7.5, 70 mM NH4Cl, 30 mM KCl,
7 mM MgCl2, 1 mM DTT, 1 mM GTP) to which 5 µM of Ala-tmRNA and 10 µM of SmpB
(2:1 volume ratio of SmpB:tmRNA) were added. A 3:1 ratio is also acceptable, but if this
ration exceed (4:1), there will be competition between the free SmpB and the complex
for binding to the ribosome. The reaction was acomplished at 37°C for 20 minutes. An
equal volume of an activated EF-Tu.GTP (40 µM EF-Tu, 2 mM GTP in 219 buffer) was
added followed by further incubation at 37°C for another 20 minutes (111).
5.2.6 Dipeptide reaction. To monitor the entrance of tmRNA inside a stalled ribosome,
a thin layer chromatography experiment (TLC) was run. The advantage of this
experiment, besides testing the tmRNA accommodation, is its ability to reveal the
activity of the ribosome. This reaction was accomplished by mixing an equal volume
from the quaternary complex described in the previous section and the ribosomal
complex (formation of this complex was described in the Materials and methods section
in CHAPTER 4) on a TLC cellulose plastic sheet 20 x 20 cm plate (EMD Chemicals Inc.,
Cat. # 5577-7). One microliter of the reaction, after incubation at different amount of
time, was loaded on the sheet 1 cm from the bottom of the plate. A solution of pyridine
acetate buffer (100 ml acetic acid and 2.5 ml pyridine in 500 ml total volume) was used
to make the sheet wet. The plate was run at 1200 V for 30 minutes in a mixture of
Stoddard solvent (Fisher, Cat. # S457-4; S457-200) and pyridine acetate. After running,
the sheet was dried under UV-lamp and exposed on a phosphorimager screen
overnight (111).
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5.2.7 Single-molecule experiment. The initiation or the elongation ribosomal complex
was formed as previously described in CHAPTER 4 (Materials and methods section), in
which a tRNA charged with N-formylmethionine or phenylalanine labeled by Cy3 (FRET
donor) is in the P site respectively. The mRNA (sequences are shown in Figure 2.9,
CHAPTER 2) was immobilized through the biotinylated DNA to the quartz slide. The
final solution was then diluted to pM scale and the molecules were allowed to bind to a
streptavidin-coated PEG slide surface once the surface was passivated with a solution
of 10 µM of bovin serum albumin and 10 µM duplex DNA in order to prevent nonspecific binding of the ribosomal complex. A flow delivery of the tmRNA-SmpB-EF-Tu
(GTP) complex that is labeled by Cy5 (FRET acceptor). The donor (ID) and acceptor (IA)
emission intensities were recorded.
5.3 Results
5.3.1 Transfer-messenger RNA entrance into the stalled ribosome is confirmed by
a thin layer chromatography TLC experiment. To confirm the entrance of the alanyltmRNA inside a stalled ribosome, thin layer chromatograph experiment (TLC) was
performed. In this experiment the initiation complex was prepared as previously
described in CHAPTER 4 (Materials and methods section). Briefly, after formylation of
tRNAfMet, the initiator tRNA was charged with a radiolabel methionine that has a
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isotope as described in the materials and methods section. The formation of the
ribosomal initiation complex was done as described in the CHAPTER 4 (materials and
methods section) (111). The quaternary complex (C14-isotopically labeled alanyltmRNAAla-SmpB-EF-Tu.GTP) was prepared as described in the materials and methods
and was added and incubated with the ribosomal complex at different time window as
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shown in the (Figure 5.5). The reaction was quenched with 0.1 M potassium hydroxide
and incubated in ice. The data revealed a dipeptide (fMet-Ala) formation by reacting the
initiator complex with the charged tmRNA. The formation of the dipeptide product (fMetAla) increased with time until reaching a plateau. The presence of dipeptide in the
reaction indicating the accommodation of the tmRNA-SmpB in the A site of the stalled
ribosome.

Figure 5.5 Dipeptide formation indicates the entrance of tmRNA in the ribosome.
Ala-tmRNA-SmpB complex was incubated with the stalled ribosome and the
reaction was quenched at different times (left to right). Samples were run on a
TLC plate (left panel). Fraction of the dipeptide formation increased with time
until it reached a plateau (right panel). The dipeptidyl fraction values were
collected by quantifying the TLC bands at each time point using Quantum Image.
5.3.2 Sm-FRET analysis of the tmRNA delivery to the stalled ribosomes. The E.coli
ribosomes missing ssrA and smpB genes were initiated on a stalled mRNA with PhetRNAPhe in the P site fluorescently labeled by Cy3 succimidyl ester at position 3-(3amino-3-carboxypropyl) uridine (acp3U47) residue that is naturally present in the E.coli
tRNAPhe. The tmRNA.SmpB.EF-Tu.GTP complex labeled by an acceptor fluorophore
(Cy5) on the mutant SmpB (alanine at position 20 is mutated to cysteine) was
introduced via stopped-flow delivery. The sm-FRET trajectories show rapid transition
between low to mid and high FRET states followed by dynamic fluctuations between
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mid and high FRET (Figure 5.6). Changes in FRET while tmRNA is accommodated
may correspond to the multistep and dynamics of the tmRNA-SmpB entrance inside the
ribosome and/or blinking events of the fluorophores (Figure 5.6 top part).
When we replace Phe-tRNAPhe by N-formylMet-tRNAfMet, we can still observe the
three FRET state (Figure 5.6 bottom part); however, the low labeling efficiency of the
tRNAfMet by the Cy3 fluorophore increased the background signal on the trajectories in
addition to the small number of molecules presents on each experiment. This problem
leads us to use in our following experiments tRNAPhe that has higher labeling efficient
(20-30%) comparing to (5%) for tRNAfMet.
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Figure 5.6 tmRNA.SmpB.EF-Tu.GTP delivery to the A site. Top part shows data
when Phe-tRNAPhe is bound to the P site of the ribosome. From the left, FRET
trace showing multiples FRET states as tmRNA is accommodated. The middle
panel shows a FRET histogram analysis from 100 molecules. Three major FRET
states were observed and fitted to Gaussian distributions (red lines). The right
panel represents the contour plot of the time evolution of the FRET populations,
where tan represents the lowest population and red represents the highest
population. Molecules at FRET ~ 0 arise from photobleaching or blinking of Cy5
as well as dissociation of tmRNA from the ribosome. Bottom part represents the
data when there is N-formylMet-tRNAfMet in the P site of the ribosome. From the
left to the right, a FRET trace, FRET histogram from 50 molecules and evolution
of the FRET states respectively.
To test our hypothesis and identify the intermediate FRET states, antibiotics
known to inhibit tmRNA selection or tmRNA fully accommodation have been used.
5.3.2 Tetracycline blocks progression of tmRNA into accommodation. The
antibiotic tetracycline is known to bind the minor groove of helix 34 and the loop of the
helix 31, and interfered with the tRNA accommodation on the A site of the ribosome (15,
136). In the presence of 100 µM tetracycline, the accommodation of the tmRNA.SmpB
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complex into the A site was inhibited. Single-molecule FRET traces revealed low FRET
state with mean value (~ 0.35), transient to mid FRET state was also observed;
however, the high FRET state was rarely observed. Our results (Figure 5.7) support the
crystal structure model proposing the mode of action of tetracycline inside the ribosome
(15, 136). In that crystal structure, it has been proposed that the initial binding of a
ternary complex (aa-tRNA-EF-Tu.GTP) and the GTPase hydrolysis by EF-Tu were not
affected by the presence of the antibiotic since the tetracycline binding site is on the
opposite site of the codon-anticodon interaction; however, after GTP hydrolysis the 30S
subunit switches from an open to closed state by moving its head down toward its body.
In this picture, tmRNA may tried to rotate into the A site to accomplish its fully
accommodation, but the presence of tetracycline creates a steric clash and leads to
expulsion of the tmRNA from the ribosome.

Figure 5.7 Tetracycline stalls the delivery of tmRNA.SmpB.EF-Tu.GTP after its
initial binding to the A site. From the left, FRET trajectories show FRET traces as
tmRNA enters the ribosome. The middle panel represents the FRET histogram
analysis after delivery of the tmRNA-SmpB-EF-Tu.GTP complex from a sum of
100 molecules. One main FRET state was observed (~0.35). The right panel
represents the contour plot of the time evolution of the FRET. Most of the
molecules in the first 10 seconds are in the low FRET state. Few of the
molecules are fluctuating between the low and the mid FRET state, and very few
demonstrate attempts to go to the high FRET state. After ~ 50 seconds, the
molecules are mostly photobleached.
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5.3.4 Kirromycin interferes with the full accommodation of tmRNA in the A site.
The full accommodation of the tmRNA inside the ribosome can be stalled after the GTP
hydrolysis using the antibiotic kirromycin. Kirromycin inhibits the translation by acting
directly on EF-Tu. In the presence of this antibiotic, EF-Tu maintains the ability to
hydrolyze the GTP, but the EF-Tu.GDP complex is hardly released from the ribosome
blocking the peptide bond formation (137). Single-molecule FRET data in the presence
of 200 µM kirromycin shows the low FRET state (mean value ~ 0.35); frequent transient
excursions to the mid FRET state were observed (≥ 0.45); however, the high FRET
state (> 0.75) was rarely found (Figure 5.8). Our results support the previously
published data on the canonical tRNA that show the role of kirromycin in blocking the
progression of tRNA to the fully accommodated step and agree with the biochemical
studies that reveal the inhibitory effect of kirromycin in the trans-translation.

Figure 5.8 Kirromycin blocks the full accommodation of the tmRNA.SmpB.EFTu.GTP complex after binding to the A site. From the left, FRET trajectories show
the tmRNA entering the ribosome. The middle panel represents a histogram
analysis of FRET states after delivery of tmRNA from the sum of 100 molecules.
Three major FRET states were shown (~0.35, ~0.6 and ~ 0.8). The right panel
represents the contour plot of the time evolution of the FRET states, where
between time 0 and the first 10 seconds approximately, most of the molecules
are in the low FRET state. Some of the molecules go to the mid FRET state and
very few reach the high FRET state before photobleaching.
5.3.5 The presence of non-hydrolysable GTP (GDPNP) prevents the tmRNA
progression into the full accommodation state. It has been shown that the tRNA
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accommodation gets stalled when EF-Tu binds GDP or GDPNP (16, 138). Singlemolecule studies have also shown that tRNA can be stalled in the pre-accommodated
state (mid FRET state) in the presence of either GDP or GDPNP. We hypothesize that
tmRNA in the presence of GDPNP acts in the same fashion as the canonical tRNA.
Single-molecule FRET data, as expected, shows molecules in the low FRET state (~
0.3) that move forward to mid FRET state (0.45-0.6); however, the high FRET state (≥
0.75) was no longer observed (Figure 5.9).

Figure 5.9 EF-Tu in the presence of non-hydrolysable GTP inhibits further
accommodation of the tmRNA.SmpB.EF-Tu.GTP. From the left, FRET
trajectories show tmRNA in the A-site of the ribosome. The middle panel
represents a histogram analysis of FRET states after delivery of tmRNA from the
sum of 39 molecules. Two FRET states were shown (~0.3 and ~ 0.45). The right
panel represents the contour plot of the time evolution of the FRET states.
5.3.6 Effect of the length of the reading frame of mRNA on the tmRNA
accommodation. It has been previously suggested that the tagging of the incompletely
synthesized protein caused by a defective mRNA is dependent on the length of mRNA
in its open reading frame (131). The entrance and tagging efficiency of tmRNA were
suggested to gradually decrease as the number of codons increases to reach near zero
when there are fifteen nucleotides and up present in the open reading frame after the P
site-codon (131). To test the effect of the mRNA length on the accommodation of
tmRNA in the A site of a stalled ribosome, a polyU mRNA with twelve nucleotides after
the P site codon in its open reading frame was used (Figure 2.9, CHAPTER 2). Single-
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molecule FRET following the same procedure as the previous experiments using in the
latter a long mRNA as a defective mRNA, the data (Figure 5.10) shows a dramatic
decrease in the population of the high FRET state comparing with a short mRNA (two
nucleotides in the open reading frame after the P site-codon, Figure 5.7 top). Since
most of the molecules (~63%) are stalled in the low FRET state (~ 0.35), blocked from
further accommodation into the A site, our results suggests a competition between the
tmRNA entrance and the open reading frame of the mRNA supporting previously
published data from the Ehrenberg laboratory (131); however, when using a short
mRNA with only two nucleotides in the A site, more than 70% of the molecules reach
the mid and high FRET states suggesting accommodation into the ribosome (Figure
5.10).

Figure 5.10 A long open reading frame competes with the entrance of tmRNA
into a stalled ribosome. From the left, FRET trajectories show FRET traces of
tmRNA in the A-site of the ribosome. The middle panel represents a histogram
analysis of FRET states after delivery of tmRNA from the sum of 98 molecules.
Three major FRET states were shown (~0.3 ~0.6 and ~ 0.8). The right panel
represents the contour plot of the time evolution of the FRET states.
5.3.7 SmpB binds the ribosome in the absence of tmRNA. A previous footprinting
study from the Ehrenberg laboratory showed that SmpB can pre-bind the ribosome to
recruit the entrance of the tmRNA-SmpB complex in the A site of a stalled ribosome
(139). On the other hand, another study from the Karzai laboratory revealed that in vitro
binding of SmpB by itself to the ribosome occurred in a high-salt dependent manner. To
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resolve this point, sm-FRET experiment was conducted by using the stalled complex
with Cy3 labeled Phe-tRNAPhe in the P site and an empty A site. Upon addition of the
Cy5-labeled SmpB, very few molecules showed binding of SmpB to the ribosome with a
FRET state (~0.5) at 15 mM magnesium ions (Figure 5.11). From our data, we couldn’t
clearly answer the question about the recruitment role of SmpB to tmRNA because of
the low number of the molecules that we can collect from our experiments

Figure 5.11 SmpB might bind the ribosome with or without tmRNA. Upper panel
represents FRET trajectories show FRET traces of SmpB in the ribosome. Lower
panel represents a histogram analysis of FRET states after delivery SmpB from
the sum of 29 molecules. One major FRET state was shown (~0.5).
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5.4 Conclusions

The trans-translation system is a requirement for diverse bacteria to execute
large changes in their genetic programs, including a response to stress, pathogenesis,
and differentiation (57). Although, significant progress has been made toward
understanding the mystery of this process, the detailed molecular mechanism still
remains to be uncovered.
Single-molecule is a powerful technique that is uniquely suited to uncovering
details of the complex molecular mechanism of trans-translation as it reveals facets of a
system otherwise hidden in common ensemble averaging techniques (140). Sm-FRET
data reveals multistep process of the tmRNA-SmpB complex toward the full
accommodation inside the ribosome. Overall, we observe three main FRET states, a
low FRET state (~ 0.35 FRET) that might represent the initial binding of tmRNA in the A
site, the mid FRET state (~0.6 FRET) which might represent the pre-accommodated
tmRNA, and a high FRET state (~0.85 FRET) that may represent the fully
accommodated tmRNA. By comparing this result with previously published data on
canonical tRNA, we hypothesized that the entrance of tmRNA might be in the same
fashion as regular tRNA; however, there might be both fast and slow exchange regimes
as suggested by fast and slow populations in the previous single-molecule work (141).
The presence of this fast exchange could both contribute to peak broadening and/or the
appearance of apparent intermediates FRET states. Another possibility is the mutant
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cysteine used for fluorophore labeling is on loop 2 of the protein and as known this part
of SmpB is flexible; this flexibility could lead to small changes in the FRET state and, in
turn, broaden the FRET peak (Figure 5.6).
The use of antibiotics was useful in assigning the various FRET states.
Tetracycline, for example, may block the progression of tmRNA into the A site, leading
us to assign the low FRET state as the initial binding of tmRNA. The mid FRET state
was characterized by kirromycin, which is another antibiotic that stalls the
accommodation of tmRNA toward the PTC center. The entrance of the tmRNA-SmpBEF-Tu.GTP complex is a multistep process that may involve structural changes in both
tmRNA and SmpB to fully accommodate the tmRNA in the PTC center. Furthermore,
this entrance is highly dependent on the length of the open reading frame of mRNA
after the P site codon. Our data (Figure 5.10 comparing to Figure 5.6) reveals the
competition between the length of the open reading frame and the entrance of tmRNA
in the stalled ribosome. This is shown in (Figure 5.10) where a high percentage of the
molecules remain in low FRET state, suggesting the tmRNA-SmpB complex tries to
enter in the ribosome but the length of mRNA blocks the accommodation.
In summary, our data illustrates the entrance and dynamics of tmRNA into the
ribosome and supports the other single molecule study, showing a multistep process
that the tmRNA-SmpB complex follows to the fully accommodation inside the A site of
the ribosome. This finding could be beneficial toward developing antibiotics that are
urgent against many pathogenic bacteria.
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CHAPTER 6
Conclusions and Future Directions

Trans-translation is a prerequisite for diverse bacteria to execute large changes
in their genetic programs, including a response to stress, pathogenesis, and
differentiation, making tmRNA an attractive target for antimicrobial drug discovery. In
recent years, extensive studies have focused on uncovering the key aspects of this
biological process. Although an enormous amount of information has been uncovered, a
great amount still remains to be explored. In this dissertation we used fluorescence
spectroscopy to investigate this mechanism based on a wealth of information from
previous genetic and biochemical assays, in addition to the cryo-EM and crystal
structure studies (49, 70, 102, 132, 139). To address this goal, first, we characterized
the structure of the tmRNA-SmpB complex in solution. Second, we developed an assay
to examine tRNA dynamics and trans-translation at the single-molecule level. Third, we
monitored the entrance and accommodation of the tmRNA-SmpB complex into stalled
ribosomes by single-molecule FRET.
The SmpB protein plays a pivotal role in trans-translation. Previous crystal
structure of the TLD-SmpB complex have suggested that SmpB mimics the anticodon
loop of canonical tRNA, and binds to the decoding center of the ribosome, whereas
the helix H2a functions as a long variable arm of class II tRNAs (103, 110). Lacking of
the crystal structure of the TLD alone poses an interesting question about whether
SmpB or Mg2+ ions modulate the TLD structure. The first aim of this dissertation was
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focused on structural characterization of the global structure of the TLD of tmRNA in
the absence and presence of SmpB and at different magnesium concentrations by
fluorescence spectroscopy. For this purpose, we designed a fluorophore-labeled
construct of TLD that is very similar to the construct used in a previous crystallographic
study of the TLD-SmpB complex (102). The fluorescence anisotropy data confirmed a
tight and specific binding of SmpB to our TLD design (KD = 1 ± 0.1 nM). We then used
steady state and time resolved FRET to monitor global conformational changes that
would alter the angle between the acceptor stem and H2a of the TLD upon interacting
with SmpB. The results showed no changes in the conformation of TLD upon SmpB
binding; however, magnesium ions stimulated a compaction on the TLD structure. This
finding has interesting implications for understanding the structural conformational
changes of tmRNA while translocating to the P site and suggests flexibility in H2a that
might help the MLD of tmRNA to replace the defective mRNA.
We next developed an assay to monitor the dynamics of tRNAs and the
accommodation of tmRNA at the single-molecule level. This technique allows
investigation of the molecular heterogeneities and short-lived intermediates in biological
complexes that are hidden in the ensemble-averaged bulk experiments. Developing of
this assay lead us to discover interesting implications of tRNA dynamics inside the
ribosome. We showed fluorophore intensity fluctuations of Cy3-labeled tRNA within a
single ribosomal binding site. We classified these fluctuations into two populations;
static and dynamic. To further understand the origin of these fluctuations, we want first
to clarify the purity of the Cy3-labeled tRNA that we used. For this purpose, we ran 20%
denaturing-PAGE gel that showed a pure fluorophore-labeled tRNA. Next, we applied
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MALDI on unlabeled and Cy3-labeled tRNA to verify the site specific labeling of Cy3 on
the naturally modified nucleotide at position 47 of tRNAPhe. Our data revealed the site
specificity of labeling. To further investigate the implications of the fluorescence
intensities fluctuations of Cy3 on the tRNA dynamics inside the ribosome, we used
antibiotics, different magnesium concentrations and different concentrations of EF-G in
the presence of a non-hydrolysable GTP (GDPNP) that are known to affect the
movement of tRNA inside the ribosome by favoring one state motion over the other. Our
results revealed that the population distribution is dependent on the identity of the tRNA
in the P site and is sensitive to the magnesium concentration and the presence of
antibiotics in the same manner as ribosomal ratcheting. Based on our results, we
suggested that the static population may represent the active population (hybrid state)
in translation where EF-G.GTP binds to and catalyzes the translocation. Overall, the
presence of these two populations is important and expected counting on the
conformational degrees of freedom of the ribosome and the flexibility of the structure of
the tRNA.
Then, we successfully monitored the entrance and the accommodation of the
(tmRNA-SmpB-EF-Tu.GTP) quaternary complex into the stalled ribosome. Our data
showed multistep processes of the accommodation of tmRNA inside stalled ribosomes,
in which three major FRET states were present. Based on our finding and comparing
our data to a previously published data on the accommodation of the canonical tRNA
inside the ribosome (16, 17), we proposed that the low FRET state may represent the
initial binding of tmRNA in the A site, the mid FRET state may correspond to the preaccommodation of tmRNA, and the high FRET state may represent the full
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accommodation of tmRNA in the A site of the stalled ribosome. Using antibiotics that
are known to block the accommodation allowed us to dissect each step in the
accommodation process. For example, tetracycline allowed us to isolate the initial
binding of the tmRNA to the ribosome. Kirromycin and the non-hydrolysable GTP
(GDPNP) let us isolate the pre-accommodated tmRNA, and the absence of the
antibiotics reveals the full process of the tmRNA accommodation. Then, we investigated
the effect of the length of the open reading frame of mRNA on the tmRNA
accommodation. For this purpose, we designed mRNA that has twelve nucleotides in
the open reading frame (polyU) and we repeated the single-molecule experiments in the
absence of antibiotics. Our data revealed the three major FRET states (low, mid and
high FRET states), but a high percentage of the molecules remain in low FRET state,
suggesting the tmRNA-SmpB complex tries to enter in the ribosome but the length of
mRNA blocks the accommodation.
Our interesting study is the first step toward exploration of the ribosome rescue
system at the single-molecule level. Still, a lot has to be uncovered to fully dissect this
mechanism. Further experiments have to be done to kinetically monitor this entrance
and understand the multi-modal binding of the tmRNA-SmpB complex to the ribosome
that was suggested by a previous single-molecule study (141). This step would be
doable by applying specific antibiotics to isolate each step as shown in CHAPTER 5.
Furthermore, to explore the later steps in the tagging process of trans-translation, the
MLD could be modified into a polyU mRNA, with a FRET donor fluorophore on the
ribosome and with a FRET acceptor fluorophore on Phe-tRNAPhe. In this approach the
wild-type S2 ribosomal protein of the 30S subunit can be replaced by a biotinylated-
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HaloTag-Cy3-S2. This commercially available Halo Tag protein can be introduced in the
S2 gene in a way that does not disrupt the structure and the function of this protein
inside the ribosome, as previously described (141). In this view, the new design (Figure
6.1) would be immobilization of the Cy3-labeled ribosome on the pEGylated slide
through the Halo Tag protein. This approach could overcome the immobilization
problem that would occur after the defective mRNA leaves the system. This would be
followed with stopped-flow delivery of Cy5-labeled-Phe-tRNAPhe.EF-Tu.GTP that would
bind to the A site of the ribosome after codon-anticodon recognition with the first UUU
codon of the MLD. FRET between the Cy3 labeled ribosome and Cy5 labeled PhetRNAPhe would be generated by exciting the Cy3 with 532 nm laser beam. This step
allows monitoring of the formation of the first peptide bond in the tagging process.

Figure 6.1 Experimental design. A biotinylated Halo-Tag-Cy3-S2 labeled
ribosome is tethered to the microscope slide via biotin-streptavidin anchor.
Peptidyl-tmRNA in the P site. Introduction of Cy5-labeled Phe-tRNAPhe in the flow
cell. Cy3 flurophore is exited by 532 nm laser beam. Emissions intensities of Cy3
and Cy5 can be detected by a CCD camera.
To observe the other steps, another laser (635 nm) may be needed that would allow us
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to monitor the accommodation of each Phe-tRNAPhe by observing the changes in the
intensity of the Cy5-labeled Phe-tRNAPhe as Phe-tRNAPhe enters the ribosome (142).
Overall, Trans-translation is vital in some of pathogenic bacteria, to contend with
this kind of microorganisms, blocking its mode of action is required. Understanding the
full trans-translation mechanism is indeed toward developing an effective inhibitor of the
SmpB-tmRNA complex that would serve as a new and novel class of antibiotics that
target the trans-translation specifically.
In this dissertation, we studied the structural conformation of the two main
components of the trans-translation that may help clarify the initiation of this process. By
developing an assay that allows us to monitor the trans-translation at the singlemolecule level, we successfully dissect the first step that crafts a drive through toward
the exploration of the ribosome rescue system.
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Single-molecule

spectroscopy,

protein-induced

fluorescence

enhancement

(PIFE), fluorescence resonance energy transfer (FRET), and several biochemical tools
were applied to study transfer RNA (tRNA) dynamics and transfer-messenger RNA
(tmRNA) accommodation inside ribosomes. In the first project of this thesis work,
structural characterization of the tRNA-like domain of tmRNA (TLD) in complex with
SmpB protein was carried out, and the results reveal no change in the global
conformation or the flexibility of the TLD upon SmpB binding. In contrast, magnesium
ions induce a compaction of the TLD structure, suggesting that flexibility in the H2a
stem of TLD may allow different conformations of tmRNA, as the TLD and mRNA-like
domain (MLD) need to be positioned differently while moving through the ribosome. In
the second project, an assay was developed to study the dynamics of tRNA and tmRNA
accommodation inside ribosomes. The results from this project reveal fluorescence
intensity changes of a dye-labeled tRNA (Cy3-tRNA) because of changes in the
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fluorophore

environment.

These

changes

are

sensitive

to

both

magnesium

concentration and the presence of antibiotics. Interestingly, these changes can be
correlated to spontaneous ribosomal ratcheting. Monitoring tmRNA entrance and
accommodation was also studied at the single-molecule level. The data reveal that the
accommodation of tmRNA occurs in a multistep process, in which three major FRET
states are present. The low FRET state might represent the initial binding of tmRNA.
The mid and high FRET states are believed to represent the pre-accommodation and
full accommodation, respectively, of tmRNA inside the ribosome. These states were
successfully assigned by using specific antibiotics that allow stalling at each FRET
state. Overall, our data suggest that the accommodation of tmRNA occurs in the same
manner as a canonical tRNA. These results have allowed the successful dissection of
the first step of the tmRNA task inside ribosomes, which is important for understanding
further steps in the pathway and unraveling the mystery of this RNA function. Such
results could be beneficial toward developing antibiotics that are urgently needed for
targeting pathogenic bacteria.
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